A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
A RNA-binding protein that is found predominately in the CYTOPLASM. It helps regulate GENETIC TRANSLATION in NEURONS and is absent or under-expressed in FRAGILE X SYNDROME.
A characteristic symptom complex.
Microsatellite repeats consisting of three nucleotides dispersed in the euchromatic arms of chromosomes.
Abnormal number or structure of the SEX CHROMOSOMES. Some sex chromosome aberrations are associated with SEX CHROMOSOME DISORDERS and SEX CHROMOSOME DISORDERS OF SEX DEVELOPMENT.
Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.
Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
An increased number of contiguous trinucleotide repeats in the DNA sequence from one generation to the next. The presence of these regions is associated with diseases such as FRAGILE X SYNDROME and MYOTONIC DYSTROPHY. Some CHROMOSOME FRAGILE SITES are composed of sequences where trinucleotide repeat expansion occurs.
Identification of genetic carriers for a given trait.
A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
Cell surface proteins that bind glutamate and act through G-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action.
A type I G protein-coupled receptor mostly expressed post-synaptic pyramidal cells of the cortex and CENTRAL NERVOUS SYSTEM.
'Nerve tissue proteins' are specialized proteins found within the nervous system's biological tissue, including neurofilaments, neuronal cytoskeletal proteins, and neural cell adhesion molecules, which facilitate structural support, intracellular communication, and synaptic connectivity essential for proper neurological function.
A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)
Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.
Transmission of emotions, ideas, and attitudes between individuals in ways other than the spoken language.
Synthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover.
Susceptibility of chromosomes to breakage leading to translocation; CHROMOSOME INVERSION; SEQUENCE DELETION; or other CHROMOSOME BREAKAGE related aberrations.
Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.
A subtype of epilepsy characterized by seizures that are consistently provoked by a certain specific stimulus. Auditory, visual, and somatosensory stimuli as well as the acts of writing, reading, eating, and decision making are examples of events or activities that may induce seizure activity in affected individuals. (From Neurol Clin 1994 Feb;12(1):57-8)
The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
Standardized tests that measure the present general ability or aptitude for intellectual performance.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
Conditions characterized by language abilities (comprehension and expression of speech and writing) that are below the expected level for a given age, generally in the absence of an intellectual impairment. These conditions may be associated with DEAFNESS; BRAIN DISEASES; MENTAL DISORDERS; or environmental factors.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Spiny processes on DENDRITES, each of which receives excitatory input from one nerve ending (NERVE ENDINGS). They are commonly found on PURKINJE CELLS and PYRAMIDAL CELLS.
Specific loci that show up during KARYOTYPING as a gap (an uncondensed stretch in closer views) on a CHROMATID arm after culturing cells under specific conditions. These sites are associated with an increase in CHROMOSOME FRAGILITY. They are classified as common or rare, and by the specific culture conditions under which they develop. Fragile site loci are named by the letters "FRA" followed by a designation for the specific chromosome, and a letter which refers to which fragile site of that chromosome (e.g. FRAXA refers to fragile site A on the X chromosome. It is a rare, folic acid-sensitive fragile site associated with FRAGILE X SYNDROME.)
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Inorganic compounds that contain lithium as an integral part of the molecule.
The ability to learn and to deal with new situations and to deal effectively with tasks involving abstractions.
An individual having different alleles at one or more loci regarding a specific character.
The language and sounds expressed by a child at a particular maturational stage in development.
Disorders of verbal and nonverbal communication caused by receptive or expressive LANGUAGE DISORDERS, cognitive dysfunction (e.g., MENTAL RETARDATION), psychiatric conditions, and HEARING DISORDERS.
An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.
Includes both producing and responding to words, either written or spoken.
Conditions characterized by deficiencies of comprehension or expression of written and spoken forms of language. These include acquired and developmental disorders.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections.
Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions.
The capacity of the NERVOUS SYSTEM to change its reactivity as the result of successive activations.
The act, process, or an instance of narrating, i.e., telling a story. In the context of MEDICINE or ETHICS, narration includes relating the particular and the personal in the life story of an individual.
The sum or the stock of words used by a language, a group, or an individual. (From Webster, 3d ed)
Tests designed to assess language behavior and abilities. They include tests of vocabulary, comprehension, grammar and functional use of language, e.g., Development Sentence Scoring, Receptive-Expressive Emergent Language Scale, Parsons Language Sample, Utah Test of Language Development, Michigan Language Inventory and Verbal Language Development Scale, Illinois Test of Psycholinguistic Abilities, Northwestern Syntax Screening Test, Peabody Picture Vocabulary Test, Ammons Full-Range Picture Vocabulary Test, and Assessment of Children's Language Comprehension.
Observable manifestations of impaired psychological functioning.
Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.
The gradual expansion in complexity and meaning of symbols and sounds as perceived and interpreted by the individual through a maturational and learning process. Stages in development include babbling, cooing, word imitation with cognition, and use of short sentences.
Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS.
A method (first developed by E.M. Southern) for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)
An individual intelligence test designed primarily for school children to predict school performance and the ability to adjust to everyday demands.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
The human female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in humans.
Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth.
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
Sequences of DNA or RNA that occur in multiple copies. There are several types: INTERSPERSED REPETITIVE SEQUENCES are copies of transposable elements (DNA TRANSPOSABLE ELEMENTS or RETROELEMENTS) dispersed throughout the genome. TERMINAL REPEAT SEQUENCES flank both ends of another sequence, for example, the long terminal repeats (LTRs) on RETROVIRUSES. Variations may be direct repeats, those occurring in the same direction, or inverted repeats, those opposite to each other in direction. TANDEM REPEAT SEQUENCES are copies which lie adjacent to each other, direct or inverted (INVERTED REPEAT SEQUENCES).

Dilemmas in counselling females with the fragile X syndrome. (1/907)

The dilemmas in counselling a mildly retarded female with the fragile X syndrome and her retarded partner are presented. The fragile X syndrome is an X linked mental retardation disorder that affects males and, often less severely, females. Affected females have an increased risk of having affected offspring. The counselling of this couple was complicated by their impaired comprehension which subsequently impaired their thinking on the different options. The woman became pregnant and underwent CVS, which showed an affected male fetus. The pregnancy was terminated. Whether nondirective counselling for this couple was the appropriate method is discussed and the importance of a system oriented approach, through involving relatives, is stressed.  (+info)

Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. (2/907)

Fragile X syndrome is caused by the absence of the fragile X mental retardation protein (FMRP). FMRP and its structural homologues FXR1P and FXR2P form a family of RNA-binding proteins (FXR proteins). The three proteins associate with polyribosomes as cytoplasmic mRNP particles. Here we show that small amounts of FMRP, FXR1P and FXR2P shuttle between cytoplasm and nucleus. Mutant FMRP of a severely affected fragile X patient (FMRPI304N) does not associate with polyribosomes and shuttles more frequently than normal FMRP, indicating that the association with polyribosomes regulates the shuttling process. Using leptomycin B we demonstrate that transport of the FXR proteins out of the nucleus is mediated by the export receptor exportin1. Finally, inactivation of the nuclear export signal in two FXR proteins shows that FMRP shuttles between cytoplasm and nucleoplasm, while FXR2P shuttles between cytoplasm and nucleolus. Therefore, molecular dissection of the shuttling routes used by the FXR proteins suggests that they transport different RNAs.  (+info)

Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. (3/907)

Fragile X syndrome is the second leading cause of mental retardation after Down syndrome. Most women carriers of the fragile X mutation are unaware of their condition. We critically evaluated whether screening pregnant women at low risk for FMR1 mutation would be feasible as a routine part of antenatal care in general practice. We also studied acceptance and attitudes to gene testing. From July 1995 until December 1996, a carrier test was offered at the Kuopio City Health Centre free of charge to all pregnant women in the first trimester following counselling given by midwives on fragile X syndrome. All women found to be carriers of FMR1 gene mutations underwent detailed genetic counselling and were offered prenatal testing. Attitudes towards the gene test were elicited by questionnaire. Most pregnant women (85%) elected to undertake the gene test. Six women were found to be carriers (a rate of 1 in 246), and all subsequently accepted prenatal testing. Three foetuses had a normal FMR1 gene, one had a large premutation, one a 'size mosaic' mutation pattern, and another a full mutation. This observational and interventional study demonstrates that antenatal screening provides an effective way of identifying carriers and incorporating prenatal testing into this process.  (+info)

Monozygotic twin brothers with the fragile X syndrome: different CGG repeats and different mental capacities. (4/907)

Little is known about the mechanism of CGG instability and the time frame of instability early in embryonic development in the fragile X syndrome. Discordant monozygotic twin brothers with the fragile X syndrome could give us insight into the time frame of the instability. We describe monochorionic diamniotic twin brothers with the fragile X syndrome who had different CGG repeats and different mental capacities, whereas the normal mother had a premutation. The more retarded brother had a full mutation in all his cells and no FMR-1 protein expression in lymphocytes, whereas the less retarded brother had 50%/50% mosaicism for a premutation and full mutation and FMR-1 protein expression in 26% of his lymphocytes. The differences in repeat size could have arisen either before or after the time of splitting. The time of splitting in this type of twin is around day 6-7. Given the high percentage of mosaicism, we hypothesise that the instability started before the time of splitting at day 6-7.  (+info)

Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. (5/907)

The preliminary results of an international collaborative study examining premature menopause in fragile X carriers are presented. A total of 760 women from fragile X families was surveyed about their fragile X carrier status and their menstrual and reproductive histories. Among the subjects, 395 carried a premutation, 128 carried a full mutation, and 237 were noncarriers. Sixty-three (16%) of the premutation carriers had experienced menopause prior to the age of 40 compared with none of the full mutation carriers and one (0.4%) of the controls. Based on these preliminary data, there is a significant association between fragile X premutation carrier status and premature menopause.  (+info)

Human werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n. (6/907)

Formation of hairpin and tetrahelical structures by a d(CGG) trinucleotide repeat sequence is thought to cause expansion of this sequence and to engender fragile X syndrome. Here we show that human Werner syndrome DNA helicase (WRN), a member of the RecQ family of helicases, efficiently unwinds G'2 bimolecular tetraplex structures of d(CGG)7. Unwinding of d(CGG)7 by WRN requires hydrolyzable ATP and Mg2+ and is proportional to the amount of added helicase and to the time of incubation. The efficiencies of unwinding of G'2 d(CGG)7 tetraplex with 7 nucleotide-long single-stranded tails at their 3' or 5' ends are, respectively, 3.5- and 2-fold greater than that of double-stranded DNA. By contrast, WRN is unable to unwind a blunt-ended d(CGG)7 tetraplex, bimolecular tetraplex structures of a telomeric sequence 5'-d(TAGACATG(TTAGGG)2TTA)-3', or tetramolecular quadruplex forms of an IgG switch region sequence 5'-d(TACAGGGGAGCTGGGGTAGA)-3'. The ability of WRN to selectively unwind specific tetrahelices may reflect a specific role of this helicase in DNA metabolism.  (+info)

Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. (7/907)

It is now recognized that female carriers of fragile X premutations are at increased risk of premature ovarian failure. We have studied 51 premenopausal women from fragile X families, to determine whether premutation carriers have variations in the hormonal markers of menopause, compared to full mutations and controls. We found a significant increase in serum follicle stimulating hormone in premutation carriers, suggesting that as a group they will enter menopause before full mutation carriers and unaffected controls. These results have important implications for fertility in these women.  (+info)

Noninvasive test for fragile X syndrome, using hair root analysis. (8/907)

Identification of the FMR1 gene and the repeat-amplification mechanism causing fragile X syndrome led to development of reliable DNA-based diagnostic methods, including Southern blot hybridization and PCR. Both methods are performed on DNA isolated from peripheral blood cells and measure the repeat size in FMR1. Using an immunocytochemical technique on blood smears, we recently developed a novel test for identification of patients with fragile X syndrome. This method, also called "antibody test," uses monoclonal antibodies against the FMR1 gene product (FMRP) and is based on absence of FMRP in patients' cells. Here we describe a new diagnostic test to identify male patients with fragile X syndrome, on the basis of lack of FMRP in their hair roots. Expression of FMRP in hair roots was studied by use of an FMRP-specific antibody test, and the percentage of FMRP-expressing hair roots in controls and in male fragile X patients was determined. Control individuals showed clear expression of FMRP in nearly every hair root, whereas male fragile X patients lacked expression of FMRP in almost all their hair roots. Mentally retarded female patients with a full mutation showed FMRP expression in only some of their hair roots (<55%), and no overlap with normal female controls was observed. The advantages of this test are (1) plucking of hair follicles does no appreciable harm to the mentally retarded patient, (2) hairs can be sent in a simple envelope to a diagnostic center, and (3) the result of the test is available within 5 h of plucking. In addition, this test enabled us to identify two fragile X patients who did not show the full mutation by analysis of DNA isolated from blood cells.  (+info)

Fragile X syndrome is a genetic disorder caused by a mutation in the FMR1 gene, which provides instructions for making a protein called fragile X mental retardation protein (FMRP). This protein is essential for normal brain development.

In people with Fragile X syndrome, the FMR1 gene is missing a critical piece of DNA, leading to little or no production of FMRP. As a result, the brain's nerve cells cannot develop and function normally, which can cause a range of developmental problems, including learning disabilities, cognitive impairment, and behavioral and emotional difficulties.

Fragile X syndrome is the most common form of inherited intellectual disability, affecting about 1 in 4,000 males and 1 in 8,000 females. The symptoms and severity can vary widely, but most people with Fragile X syndrome have some degree of intellectual disability, ranging from mild to severe. They may also have physical features associated with the condition, such as a long face, large ears, flexible joints, and flat feet.

There is no cure for Fragile X syndrome, but early intervention and treatment can help improve outcomes. Treatment typically involves a combination of educational support, behavioral therapy, speech and language therapy, physical therapy, and medication to manage symptoms such as anxiety, hyperactivity, and aggression.

Fragile X Mental Retardation Protein (FMRP) is a protein encoded by the FMR1 gene in humans. It is an RNA-binding protein that plays a critical role in regulating the translation and stability of mRNAs, particularly those involved in synaptic plasticity and neuronal development.

Mutations in the FMR1 gene, leading to the absence or reduction of FMRP, have been associated with Fragile X syndrome (FXS), which is the most common inherited form of intellectual disability and the leading genetic cause of autism spectrum disorder (ASD). In FXS, the lack of FMRP leads to an overproduction of proteins at synapses, resulting in altered neuronal connectivity and dysfunctional synaptic plasticity.

FMRP is widely expressed in various tissues, but it has a particularly high expression level in the brain, where it regulates the translation of mRNAs involved in learning, memory, and other cognitive functions. FMRP also interacts with several other proteins involved in neuronal development and function, such as ion channels, receptors, and signaling molecules.

Overall, Fragile X Mental Retardation Protein is a crucial regulator of synaptic plasticity and neuronal development, and its dysfunction has been linked to various neurodevelopmental disorders, including Fragile X syndrome, autism spectrum disorder, and intellectual disability.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

Trinucleotide repeats refer to a specific type of DNA sequence expansion where a particular trinucleotide (a sequence made up of three nucleotides) is repeated multiple times. In normal genomic DNA, these repeats are usually present in a relatively stable and consistent range. However, when the number of repeats exceeds a certain threshold, it can result in an unstable genetic variant known as a trinucleotide repeat expansion.

These expansions can occur in various genes and are associated with several neurogenetic disorders, such as Huntington's disease, myotonic dystrophy, fragile X syndrome, and Friedreich's ataxia. The length of the trinucleotide repeat tends to expand further in subsequent generations, which can lead to anticipation – an earlier age of onset and increased severity of symptoms in successive generations.

The most common trinucleotide repeats involve CAG (cytosine-adenine-guanine) or CTG (cytosine-thymine-guanine) repeats, although other combinations like CGG, GAA, and GCT can also be involved. These repeat expansions can result in altered gene function, protein misfolding, aggregation, and toxicity, ultimately leading to the development of neurodegenerative diseases and other clinical manifestations.

Sex chromosome aberrations refer to structural and numerical abnormalities in the sex chromosomes, which are typically represented as X and Y chromosomes in humans. These aberrations can result in variations in the number of sex chromosomes, such as Klinefelter syndrome (47,XXY), Turner syndrome (45,X), and Jacobs/XYY syndrome (47,XYY). They can also include structural changes, such as deletions, duplications, or translocations of sex chromosome material.

Sex chromosome aberrations may lead to a range of phenotypic effects, including differences in physical characteristics, cognitive development, fertility, and susceptibility to certain health conditions. The manifestation and severity of these impacts can vary widely depending on the specific type and extent of the aberration, as well as individual genetic factors and environmental influences.

It is important to note that while sex chromosome aberrations may pose challenges and require medical management, they do not inherently define or limit a person's potential, identity, or worth. Comprehensive care, support, and education can help individuals with sex chromosome aberrations lead fulfilling lives and reach their full potential.

RNA-binding proteins (RBPs) are a class of proteins that selectively interact with RNA molecules to form ribonucleoprotein complexes. These proteins play crucial roles in the post-transcriptional regulation of gene expression, including pre-mRNA processing, mRNA stability, transport, localization, and translation. RBPs recognize specific RNA sequences or structures through their modular RNA-binding domains, which can be highly degenerate and allow for the recognition of a wide range of RNA targets. The interaction between RBPs and RNA is often dynamic and can be regulated by various post-translational modifications of the proteins or by environmental stimuli, allowing for fine-tuning of gene expression in response to changing cellular needs. Dysregulation of RBP function has been implicated in various human diseases, including neurological disorders and cancer.

Intellectual disability (ID) is a term used when there are significant limitations in both intellectual functioning and adaptive behavior, which covers many everyday social and practical skills. This disability originates before the age of 18.

Intellectual functioning, also known as intelligence, refers to general mental capacity, such as learning, reasoning, problem-solving, and other cognitive skills. Adaptive behavior includes skills needed for day-to-day life, such as communication, self-care, social skills, safety judgement, and basic academic skills.

Intellectual disability is characterized by below-average intelligence or mental ability and a lack of skills necessary for day-to-day living. It can be mild, moderate, severe, or profound, depending on the degree of limitation in intellectual functioning and adaptive behavior.

It's important to note that people with intellectual disabilities have unique strengths and limitations, just like everyone else. With appropriate support and education, they can lead fulfilling lives and contribute to their communities in many ways.

Trinucleotide Repeat Expansion is a genetic mutation where a sequence of three DNA nucleotides is repeated more frequently than what is typically found in the general population. In this type of mutation, the number of repeats can expand or increase from one generation to the next, leading to an increased risk of developing certain genetic disorders.

These disorders are often neurological and include conditions such as Huntington's disease, myotonic dystrophy, fragile X syndrome, and Friedreich's ataxia. The severity of these diseases can be related to the number of repeats present in the affected gene, with a higher number of repeats leading to more severe symptoms or an earlier age of onset.

It is important to note that not all trinucleotide repeat expansions will result in disease, and some people may carry these mutations without ever developing any symptoms. However, if the number of repeats crosses a certain threshold, it can lead to genetic instability and an increased risk of disease development.

Heterozygote detection is a method used in genetics to identify individuals who carry one normal and one mutated copy of a gene. These individuals are known as heterozygotes and they do not typically show symptoms of the genetic disorder associated with the mutation, but they can pass the mutated gene on to their offspring, who may then be affected.

Heterozygote detection is often used in genetic counseling and screening programs for recessive disorders such as cystic fibrosis or sickle cell anemia. By identifying heterozygotes, individuals can be informed of their carrier status and the potential risks to their offspring. This information can help them make informed decisions about family planning and reproductive options.

Various methods can be used for heterozygote detection, including polymerase chain reaction (PCR) based tests, DNA sequencing, and genetic linkage analysis. The choice of method depends on the specific gene or mutation being tested, as well as the availability and cost of the testing technology.

Autistic Disorder, also known as Autism or Classic Autism, is a neurodevelopmental disorder that affects communication and behavior. It is characterized by:

1. Persistent deficits in social communication and social interaction across multiple contexts, including:
* Deficits in social-emotional reciprocity;
* Deficits in nonverbal communicative behaviors used for social interaction;
* Deficits in developing, maintaining, and understanding relationships.
2. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least two of the following:
* Stereotyped or repetitive motor movements, use of objects, or speech;
* Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal behavior;
* Highly restricted, fixated interests that are abnormal in intensity or focus;
* Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment.
3. Symptoms must be present in the early developmental period (but may not become fully manifest until social demands exceed limited capacities) and limit or impair everyday functioning.
4. Symptoms do not occur exclusively during the course of a schizophrenia spectrum disorder or other psychotic disorders.

Autistic Disorder is part of the autism spectrum disorders (ASDs), which also include Asperger's Syndrome and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). The current diagnostic term for this category of conditions, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is Autism Spectrum Disorder.

Metabotropic glutamate receptors (mGluRs) are a type of G protein-coupled receptor (GPCR) that are activated by the neurotransmitter glutamate, which is the primary excitatory neurotransmitter in the central nervous system. There are eight different subtypes of mGluRs, labeled mGluR1 through mGluR8, which are classified into three groups (Group I, II, and III) based on their sequence homology, downstream signaling pathways, and pharmacological properties.

Group I mGluRs include mGluR1 and mGluR5, which are primarily located postsynaptically in the central nervous system. Activation of Group I mGluRs leads to increased intracellular calcium levels and activation of protein kinases, which can modulate synaptic transmission and plasticity.

Group II mGluRs include mGluR2 and mGluR3, which are primarily located presynaptically in the central nervous system. Activation of Group II mGluRs inhibits adenylyl cyclase activity and reduces neurotransmitter release.

Group III mGluRs include mGluR4, mGluR6, mGluR7, and mGluR8, which are also primarily located presynaptically in the central nervous system. Activation of Group III mGluRs inhibits adenylyl cyclase activity and voltage-gated calcium channels, reducing neurotransmitter release.

Overall, metabotropic glutamate receptors play important roles in modulating synaptic transmission and plasticity, and have been implicated in various neurological disorders, including epilepsy, pain, anxiety, depression, and neurodegenerative diseases.

A metabotropic glutamate receptor 5 (mGluR5) is a type of G protein-coupled receptor that binds to the neurotransmitter glutamate, which is the primary excitatory neurotransmitter in the brain. When activated, mGluR5 receptors trigger a variety of intracellular signaling pathways that modulate synaptic transmission, neuronal excitability, and neural plasticity.

mGluR5 receptors are widely expressed throughout the central nervous system, where they play important roles in various physiological processes, including learning and memory, anxiety, addiction, and pain perception. Dysregulation of mGluR5 signaling has been implicated in several neurological and psychiatric disorders, such as fragile X syndrome, Parkinson's disease, schizophrenia, and drug addiction.

Pharmacological targeting of mGluR5 receptors has emerged as a promising therapeutic strategy for the treatment of these disorders. Positive allosteric modulators (PAMs) of mGluR5 have shown potential in preclinical studies for improving cognitive function and reducing negative symptoms in schizophrenia, while negative allosteric modulators (NAMs) have shown promise in preclinical models of fragile X syndrome, Parkinson's disease, and addiction.

Nerve tissue proteins are specialized proteins found in the nervous system that provide structural and functional support to nerve cells, also known as neurons. These proteins include:

1. Neurofilaments: These are type IV intermediate filaments that provide structural support to neurons and help maintain their shape and size. They are composed of three subunits - NFL (light), NFM (medium), and NFH (heavy).

2. Neuronal Cytoskeletal Proteins: These include tubulins, actins, and spectrins that provide structural support to the neuronal cytoskeleton and help maintain its integrity.

3. Neurotransmitter Receptors: These are specialized proteins located on the postsynaptic membrane of neurons that bind neurotransmitters released by presynaptic neurons, triggering a response in the target cell.

4. Ion Channels: These are transmembrane proteins that regulate the flow of ions across the neuronal membrane and play a crucial role in generating and transmitting electrical signals in neurons.

5. Signaling Proteins: These include enzymes, receptors, and adaptor proteins that mediate intracellular signaling pathways involved in neuronal development, differentiation, survival, and death.

6. Adhesion Proteins: These are cell surface proteins that mediate cell-cell and cell-matrix interactions, playing a crucial role in the formation and maintenance of neural circuits.

7. Extracellular Matrix Proteins: These include proteoglycans, laminins, and collagens that provide structural support to nerve tissue and regulate neuronal migration, differentiation, and survival.

Down syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is characterized by intellectual and developmental disabilities, distinctive facial features, and sometimes physical growth delays and health problems. The condition affects approximately one in every 700 babies born in the United States.

Individuals with Down syndrome have varying degrees of cognitive impairment, ranging from mild to moderate or severe. They may also have delayed development, including late walking and talking, and may require additional support and education services throughout their lives.

People with Down syndrome are at increased risk for certain health conditions, such as congenital heart defects, respiratory infections, hearing loss, vision problems, gastrointestinal issues, and thyroid disorders. However, many individuals with Down syndrome live healthy and fulfilling lives with appropriate medical care and support.

The condition is named after John Langdon Down, an English physician who first described the syndrome in 1866.

Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Genetic tests are performed on a sample of blood, hair, skin, amniotic fluid (the fluid that surrounds a fetus during pregnancy), or other tissue. For example, a physician may recommend genetic testing to help diagnose a genetic condition, confirm the presence of a gene mutation known to increase the risk of developing certain cancers, or determine the chance for a couple to have a child with a genetic disorder.

There are several types of genetic tests, including:

* Diagnostic testing: This type of test is used to identify or confirm a suspected genetic condition in an individual. It may be performed before birth (prenatal testing) or at any time during a person's life.
* Predictive testing: This type of test is used to determine the likelihood that a person will develop a genetic disorder. It is typically offered to individuals who have a family history of a genetic condition but do not show any symptoms themselves.
* Carrier testing: This type of test is used to determine whether a person carries a gene mutation for a genetic disorder. It is often offered to couples who are planning to have children and have a family history of a genetic condition or belong to a population that has an increased risk of certain genetic disorders.
* Preimplantation genetic testing: This type of test is used in conjunction with in vitro fertilization (IVF) to identify genetic changes in embryos before they are implanted in the uterus. It can help couples who have a family history of a genetic disorder or who are at risk of having a child with a genetic condition to conceive a child who is free of the genetic change in question.
* Pharmacogenetic testing: This type of test is used to determine how an individual's genes may affect their response to certain medications. It can help healthcare providers choose the most effective medication and dosage for a patient, reducing the risk of adverse drug reactions.

It is important to note that genetic testing should be performed under the guidance of a qualified healthcare professional who can interpret the results and provide appropriate counseling and support.

Nonverbal communication in a medical context refers to the transmission of information or messages through visual, auditory, tactile, olfactory, and kinesthetic channels, excluding spoken or written language. It includes facial expressions, body posture, gestures, eye contact, touch, physical appearance, use of space, and paralanguages such as tone of voice, volume, and pitch. In healthcare settings, nonverbal communication plays a crucial role in building rapport, expressing empathy, conveying emotions, and understanding patients' needs and concerns. Healthcare providers should be aware of their own nonverbal cues and interpret those of their patients to enhance clinical encounters and improve patient-centered care.

Methoxyhydroxyphenylglycol (MHPG) is a major metabolite of the neurotransmitter norepinephrine, which is synthesized in the body from the amino acid tyrosine. Norepinephrine plays important roles in various physiological functions such as the cardiovascular system, respiratory system, and central nervous system. MHPG is formed when norepinephrine is metabolized by enzymes called catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO).

MHPG is primarily found in the urine, and its levels can be measured to assess norepinephrine turnover in the body. Changes in MHPG levels have been associated with various medical conditions, including depression, anxiety disorders, and neurodegenerative diseases such as Parkinson's disease. However, the clinical utility of measuring MHPG levels is still a subject of ongoing research and debate.

Chromosome fragility refers to the susceptibility of specific regions on chromosomes to break or become unstable during cell division. These fragile sites are prone to forming gaps or breaks in the chromosome structure, which can lead to genetic rearrangements, including deletions, duplications, or translocations.

Chromosome fragility is often associated with certain genetic disorders and syndromes. For example, the most common fragile site in human chromosomes is FRAXA, located on the X chromosome, which is linked to Fragile X Syndrome, a leading cause of inherited intellectual disability and autism.

Environmental factors such as exposure to chemicals or radiation can also increase chromosome fragility, leading to an increased risk of genetic mutations and diseases.

Pervasive developmental disorders (PDD) are a group of conditions that affect the development and functioning of the brain, leading to delays in many areas of development. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) has replaced the term "pervasive developmental disorders" with "autism spectrum disorder" and "other neurodevelopmental disorders."

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction across multiple contexts, as well as restricted, repetitive patterns of behavior, interests, or activities. The symptoms of ASD can range from mild to severe, and the condition affects approximately 1 in 54 children in the United States.

Other neurodevelopmental disorders that were previously classified as PDDs include:

1. Intellectual disability (ID): a condition characterized by significant limitations in intellectual functioning and adaptive behavior, which covers many everyday social and practical skills. This disorder used to be referred to as "mental retardation."
2. Communication disorders: these are disorders that affect an individual's ability to communicate, including language disorders, speech sound disorders, and stuttering.
3. Attention-deficit/hyperactivity disorder (ADHD): a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity.
4. Specific learning disorder: a neurodevelopmental disorder that affects an individual's ability to learn and use specific academic skills, such as reading, writing, or mathematics.
5. Motor disorders: these are disorders that affect an individual's movement and coordination, including developmental coordination disorder, stereotypic movement disorder, and tic disorders.

The medical definition of 'Child Development Disorders, Pervasive' has been replaced with more specific diagnoses in the DSM-5 to better reflect the diverse nature of these conditions and improve diagnostic accuracy and treatment planning.

The X chromosome is one of the two types of sex-determining chromosomes in humans (the other being the Y chromosome). It's one of the 23 pairs of chromosomes that make up a person's genetic material. Females typically have two copies of the X chromosome (XX), while males usually have one X and one Y chromosome (XY).

The X chromosome contains hundreds of genes that are responsible for the production of various proteins, many of which are essential for normal bodily functions. Some of the critical roles of the X chromosome include:

1. Sex Determination: The presence or absence of the Y chromosome determines whether an individual is male or female. If there is no Y chromosome, the individual will typically develop as a female.
2. Genetic Disorders: Since females have two copies of the X chromosome, they are less likely to be affected by X-linked genetic disorders than males. Males, having only one X chromosome, will express any recessive X-linked traits they inherit.
3. Dosage Compensation: To compensate for the difference in gene dosage between males and females, a process called X-inactivation occurs during female embryonic development. One of the two X chromosomes is randomly inactivated in each cell, resulting in a single functional copy per cell.

The X chromosome plays a crucial role in human genetics and development, contributing to various traits and characteristics, including sex determination and dosage compensation.

Reflex epilepsy is a type of epilepsy in which seizures are consistently triggered by specific, recurring sensory stimuli. These triggers can vary widely and may include visual patterns, flashes of light, touch, sound, or even emotional experiences. When the brain receives input from these triggers, it responds with an abnormal electrical discharge that can lead to a seizure.

Reflex epilepsy is relatively rare, accounting for only about 5-10% of all epilepsy cases. It's important to note that not everyone who experiences seizures in response to these triggers has reflex epilepsy; the defining characteristic of this condition is the consistent and reproducible nature of the seizure response to a specific stimulus.

There are several different types of reflex epilepsy, each characterized by its own unique set of triggers. For example, some people with this condition may experience seizures in response to visual patterns or flashes of light (known as photosensitive epilepsy), while others may have seizures triggered by certain sounds or tactile sensations.

Treatment for reflex epilepsy typically involves identifying and avoiding triggers whenever possible, as well as using medication to control seizures. In some cases, surgery may be recommended to remove the specific area of the brain that is responsible for the abnormal electrical activity. With proper treatment and management, many people with reflex epilepsy are able to lead full and active lives.

Mosaicism, in the context of genetics and medicine, refers to the presence of two or more cell lines with different genetic compositions in an individual who has developed from a single fertilized egg. This means that some cells have one genetic makeup, while others have a different genetic makeup. This condition can occur due to various reasons such as errors during cell division after fertilization.

Mosaicism can involve chromosomes (where whole or parts of chromosomes are present in some cells but not in others) or it can involve single genes (where a particular gene is present in one form in some cells and a different form in others). The symptoms and severity of mosaicism can vary widely, depending on the type and location of the genetic difference and the proportion of cells that are affected. Some individuals with mosaicism may not experience any noticeable effects, while others may have significant health problems.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

Ataxia is a medical term that refers to a group of disorders affecting coordination, balance, and speech. It is characterized by a lack of muscle control during voluntary movements, causing unsteady or awkward movements, and often accompanied by tremors. Ataxia can affect various parts of the body, such as the limbs, trunk, eyes, and speech muscles. The condition can be congenital or acquired, and it can result from damage to the cerebellum, spinal cord, or sensory nerves. There are several types of ataxia, including hereditary ataxias, degenerative ataxias, cerebellar ataxias, and acquired ataxias, each with its own specific causes, symptoms, and prognosis. Treatment for ataxia typically focuses on managing symptoms and improving quality of life, as there is no cure for most forms of the disorder.

Intelligence tests are standardized procedures used to assess various aspects of an individual's cognitive abilities, such as their problem-solving skills, logical reasoning, verbal comprehension, and spatial relations. These tests provide a quantitative measurement of intelligence, often reported as an Intelligence Quotient (IQ) score. It is important to note that intelligence is a multifaceted concept, and intelligence tests measure only certain aspects of it. They should not be considered the sole determinant of an individual's overall intellectual capabilities or potential.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

A tremor is an involuntary, rhythmic muscle contraction and relaxation that causes a shaking movement. It's a type of motion disorder that can affect any part of your body, but it most often occurs in your hands. Tremors can be harmless, but they can also be a symptom of a more serious neurological disorder. The cause of tremors isn't always known, but they can be the result of damage to the brain from a stroke, multiple sclerosis, or trauma. Certain medications, alcohol abuse, and drug withdrawal can also cause tremors. In some cases, tremors may be inherited and run in families.

Tremors can be classified based on their cause, appearance, and the situation in which they occur. The two most common types of tremors are:

* Resting tremors, which occur when your muscles are relaxed, such as when your hands are resting on your lap. Parkinson's disease is a common cause of this type of tremor.
* Action tremors, which occur with purposeful movement, such as when you're trying to hold something or when you're using a utensil. Essential tremor, the most common type of tremor, is an action tremor.

Tremors can also be classified based on their frequency (how often they occur) and amplitude (the size of the movement). High-frequency tremors are faster and smaller in amplitude, while low-frequency tremors are slower and larger in amplitude.

In general, tremors are not a life-threatening condition, but they can be embarrassing or make it difficult to perform daily activities. In some cases, tremors may indicate a more serious underlying condition that requires treatment. If you're concerned about tremors or have any questions about your symptoms, it's important to speak with a healthcare provider for an accurate diagnosis and appropriate treatment.

Language development disorders, also known as language impairments or communication disorders, refer to a group of conditions that affect an individual's ability to understand and/or use spoken or written language in a typical manner. These disorders can manifest as difficulties with grammar, vocabulary, sentence structure, word finding, following directions, and/or conversational skills.

Language development disorders can be receptive (difficulty understanding language), expressive (difficulty using language to communicate), or mixed (a combination of both). They can occur in isolation or as part of a broader neurodevelopmental disorder, such as autism spectrum disorder or intellectual disability.

The causes of language development disorders are varied and may include genetic factors, environmental influences, neurological conditions, hearing loss, or other medical conditions. It is important to note that language development disorders are not the result of low intelligence or lack of motivation; rather, they reflect a specific impairment in the brain's language processing systems.

Early identification and intervention for language development disorders can significantly improve outcomes and help individuals develop effective communication skills. Treatment typically involves speech-language therapy, which may be provided individually or in a group setting, and may involve strategies such as modeling correct language use, practicing targeted language skills, and using visual aids to support comprehension.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Dendritic spines are small, specialized protrusions found on the dendrites of neurons, which are cells that transmit information in the nervous system. These structures receive and process signals from other neurons. Dendritic spines have a small head connected to the dendrite by a thin neck, and they vary in shape, size, and number depending on the type of neuron and its function. They are dynamic structures that can change their morphology and strength of connections with other neurons in response to various stimuli, such as learning and memory processes.

Chromosome fragile sites are specific locations along the length of a chromosome that are prone to breakage or rearrangement when exposed to certain chemicals or conditions, such as replication stress during cell division. These sites are often characterized by the presence of repetitive DNA sequences and proteins that help maintain the stability of the chromosome.

Fragile sites can be classified into two categories: common and rare. Common fragile sites are present in most individuals and are typically not associated with genetic disorders, while rare fragile sites are less common and may be linked to specific genetic conditions or increased risk for cancer.

When a chromosome breaks at a fragile site, it can lead to various genetic abnormalities such as deletions, duplications, inversions, or translocations of genetic material. These changes can have significant consequences on gene expression and function, potentially leading to developmental disorders, intellectual disability, cancer, or other health issues.

It is important to note that not all fragile sites will result in genetic abnormalities, as some may remain stable under normal conditions. However, certain factors such as environmental exposures, aging, or inherited genetic predispositions can increase the likelihood of chromosomal instability at fragile sites.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Lithium compounds refer to chemical substances that contain the element lithium (Li) combined with one or more other elements. Lithium is an alkali metal with the atomic number 3 and is highly reactive, so it is typically found in nature combined with other elements to form stable compounds.

Lithium compounds have a variety of uses, including in the production of ceramics, glass, and lubricants. However, they are perhaps best known for their use in psychiatric medicine, particularly in the treatment of bipolar disorder. Lithium carbonate (Li2CO3) is the most commonly prescribed lithium compound for this purpose.

Lithium compounds work by affecting the levels of certain neurotransmitters in the brain, including serotonin and dopamine. They can help to reduce the severity and frequency of manic episodes in people with bipolar disorder, as well as potentially having a mood-stabilizing effect. It is important to note that lithium compounds must be used under the close supervision of a healthcare provider, as they can have serious side effects if not properly monitored.

I must clarify that I cannot provide a "medical definition" of intelligence, as intelligence is not a concept that is typically defined within the field of medicine. Intelligence is a term used to describe the ability to learn, understand, and make judgments or decisions based on reason, experience, and information. It is often measured through various cognitive abilities such as problem-solving, critical thinking, creativity, and knowledge acquisition.

The concept of intelligence is studied in many fields, including psychology, neuroscience, and education. In medicine, healthcare professionals may assess a person's cognitive abilities to better understand their health status or develop treatment plans. However, there is no specific "medical definition" for intelligence. Instead, it is a multifaceted concept that can be influenced by various genetic, environmental, and experiential factors.

A heterozygote is an individual who has inherited two different alleles (versions) of a particular gene, one from each parent. This means that the individual's genotype for that gene contains both a dominant and a recessive allele. The dominant allele will be expressed phenotypically (outwardly visible), while the recessive allele may or may not have any effect on the individual's observable traits, depending on the specific gene and its function. Heterozygotes are often represented as 'Aa', where 'A' is the dominant allele and 'a' is the recessive allele.

Child language refers to the development of linguistic abilities in children, including both receptive and expressive communication. This includes the acquisition of various components of language such as phonology (sound system), morphology (word structure), syntax (sentence structure), semantics (meaning), and pragmatics (social use of language).

Child language development typically follows a predictable sequence, beginning with cooing and babbling in infancy, followed by the use of single words and simple phrases in early childhood. Over time, children acquire more complex linguistic structures and expand their vocabulary to communicate more effectively. However, individual differences in the rate and pace of language development are common.

Clinical professionals such as speech-language pathologists may assess and diagnose children with language disorders or delays in order to provide appropriate interventions and support for typical language development.

Communication disorders refer to a group of disorders that affect a person's ability to receive, send, process, and understand concepts or verbal, nonverbal, and written communication. These disorders can be language-based, speech-based, or hearing-based.

Language-based communication disorders include:

1. Aphasia - a disorder that affects a person's ability to understand or produce spoken or written language due to damage to the brain's language centers.
2. Language development disorder - a condition where a child has difficulty developing age-appropriate language skills.
3. Dysarthria - a motor speech disorder that makes it difficult for a person to control the muscles used for speaking, resulting in slurred or slow speech.
4. Stuttering - a speech disorder characterized by repetition of sounds, syllables, or words, prolongation of sounds, and interruptions in speech known as blocks.
5. Voice disorders - problems with the pitch, volume, or quality of the voice that make it difficult to communicate effectively.

Hearing-based communication disorders include:

1. Hearing loss - a partial or complete inability to hear sound in one or both ears.
2. Auditory processing disorder - a hearing problem where the brain has difficulty interpreting the sounds heard, even though the person's hearing is normal.

Communication disorders can significantly impact a person's ability to interact with others and perform daily activities. Early identification and intervention are crucial for improving communication skills and overall quality of life.

Genetic counseling is a process of communication and education between a healthcare professional and an individual or family, aimed at understanding, adapting to, and managing the medical, psychological, and familial implications of genetic contributions to disease. This includes providing information about the risk of inherited conditions, explaining the implications of test results, discussing reproductive options, and offering support and resources for coping with a genetic condition. Genetic counselors are trained healthcare professionals who specialize in helping people understand genetic information and its impact on their health and lives.

In the context of medical and clinical psychology, particularly in the field of applied behavior analysis (ABA), "verbal behavior" is a term used to describe the various functions or purposes of spoken language. It was first introduced by the psychologist B.F. Skinner in his 1957 book "Verbal Behavior."

Skinner proposed that verbal behavior could be classified into several categories based on its function, including:

1. Mand: A verbal operant in which a person requests or demands something from another person. For example, saying "I would like a glass of water" is a mand.
2. Tact: A verbal operant in which a person describes or labels something in their environment. For example, saying "That's a red apple" is a tact.
3. Echoic: A verbal operant in which a person repeats or imitates what they have heard. For example, saying "Hello" after someone says hello to you is an echoic.
4. Intraverbal: A verbal operant in which a person responds to another person's verbal behavior with their own verbal behavior, without simply repeating or imitating what they have heard. For example, answering a question like "What's the capital of France?" is an intraverbal.
5. Textual: A verbal operant in which a person reads or writes text. For example, reading a book or writing a letter are textual.

Understanding the function of verbal behavior can be helpful in assessing and treating communication disorders, such as those seen in autism spectrum disorder (ASD). By identifying the specific functions of a child's verbal behavior, therapists can develop targeted interventions to help them communicate more effectively.

Language disorders, also known as communication disorders, refer to a group of conditions that affect an individual's ability to understand or produce spoken, written, or other symbolic language. These disorders can be receptive (difficulty understanding language), expressive (difficulty producing language), or mixed (a combination of both).

Language disorders can manifest as difficulties with grammar, vocabulary, sentence structure, and coherence in communication. They can also affect social communication skills such as taking turns in conversation, understanding nonverbal cues, and interpreting tone of voice.

Language disorders can be developmental, meaning they are present from birth or early childhood, or acquired, meaning they develop later in life due to injury, illness, or trauma. Examples of acquired language disorders include aphasia, which can result from stroke or brain injury, and dysarthria, which can result from neurological conditions affecting speech muscles.

Language disorders can have significant impacts on an individual's academic, social, and vocational functioning, making it important to diagnose and treat them as early as possible. Treatment typically involves speech-language therapy to help individuals develop and improve their language skills.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Primary Ovarian Insufficiency (POI), also known as Premature Ovarian Failure, is a condition characterized by the cessation of ovarian function before the age of 40. This results in decreased estrogen production and loss of fertility. It is often associated with menstrual irregularities or amenorrhea (absence of menstruation). The exact cause can vary, including genetic factors, autoimmune diseases, toxins, and iatrogenic causes such as chemotherapy or radiation therapy.

A synapse is a structure in the nervous system that allows for the transmission of signals from one neuron (nerve cell) to another. It is the point where the axon terminal of one neuron meets the dendrite or cell body of another, and it is here that neurotransmitters are released and received. The synapse includes both the presynaptic and postsynaptic elements, as well as the cleft between them.

At the presynaptic side, an action potential travels down the axon and triggers the release of neurotransmitters into the synaptic cleft through exocytosis. These neurotransmitters then bind to receptors on the postsynaptic side, which can either excite or inhibit the receiving neuron. The strength of the signal between two neurons is determined by the number and efficiency of these synapses.

Synapses play a crucial role in the functioning of the nervous system, allowing for the integration and processing of information from various sources. They are also dynamic structures that can undergo changes in response to experience or injury, which has important implications for learning, memory, and recovery from neurological disorders.

Neuronal plasticity, also known as neuroplasticity or neural plasticity, refers to the ability of the brain and nervous system to change and adapt as a result of experience, learning, injury, or disease. This can involve changes in the structure, organization, and function of neurons (nerve cells) and their connections (synapses) in the central and peripheral nervous systems.

Neuronal plasticity can take many forms, including:

* Synaptic plasticity: Changes in the strength or efficiency of synaptic connections between neurons. This can involve the formation, elimination, or modification of synapses.
* Neural circuit plasticity: Changes in the organization and connectivity of neural circuits, which are networks of interconnected neurons that process information.
* Structural plasticity: Changes in the physical structure of neurons, such as the growth or retraction of dendrites (branches that receive input from other neurons) or axons (projections that transmit signals to other neurons).
* Functional plasticity: Changes in the physiological properties of neurons, such as their excitability, responsiveness, or sensitivity to stimuli.

Neuronal plasticity is a fundamental property of the nervous system and plays a crucial role in many aspects of brain function, including learning, memory, perception, and cognition. It also contributes to the brain's ability to recover from injury or disease, such as stroke or traumatic brain injury.

In the context of medicine, "narration" typically refers to the description or telling of a patient's history, symptoms, and course of illness. It is the process of recounting the important medical events and experiences related to a patient's health status. This information is usually gathered through interviews, physical examinations, and review of medical records. The resulting narrative can help healthcare providers understand the patient's condition, make informed decisions about diagnosis and treatment, and provide appropriate care. However, it's important to note that "narration" itself is not a medical term, but rather a general term used in many fields including medicine.

I'm sorry for any confusion, but "vocabulary" is a term related to language and communication, rather than medicine or healthcare. It refers to the words and phrases that a person knows and uses in their communication. If you have any questions related to medical terminology or health-related topics, I would be happy to help with those!

A language test is not a medical term per se, but it is commonly used in the field of speech-language pathology, which is a medical discipline. A language test, in this context, refers to an assessment tool used by speech-language pathologists to evaluate an individual's language abilities. These tests typically measure various aspects of language, including vocabulary, grammar, syntax, semantics, and pragmatics.

Language tests can be standardized or non-standardized and may be administered individually or in a group setting. The results of these tests help speech-language pathologists diagnose language disorders, develop treatment plans, and monitor progress over time. It is important to note that language testing should be conducted by a qualified professional who has experience in administering and interpreting language assessments.

Behavioral symptoms refer to changes or abnormalities in a person's behavior, which may be indicative of an underlying medical or psychological condition. These symptoms can manifest as a wide range of observable behaviors that are unusual, disruptive, or distressing for the individual experiencing them or those around them. Examples of behavioral symptoms include:

1. Agitation: A state of irritability, restlessness, or excitement, often accompanied by aggressive or disruptive behavior.
2. Aggression: Hostile or violent behavior directed towards others, including verbal or physical attacks.
3. Apathy: A lack of interest, motivation, or emotion, often leading to social withdrawal and decreased activity levels.
4. Changes in appetite or sleep patterns: Significant fluctuations in the amount or frequency of food intake or sleep, which can be indicative of various medical or psychological conditions.
5. Disinhibition: A loss of restraint or impulse control, leading to inappropriate behavior in social situations.
6. Hallucinations: Perception of sensory stimuli (such as sight, sound, touch) without an external source, often associated with certain mental illnesses or neurological disorders.
7. Hyperactivity: Increased activity levels, often accompanied by impulsivity and difficulty focusing attention.
8. Impaired judgment: Poor decision-making abilities, often resulting in risky or harmful behavior.
9. Inattention: Difficulty focusing or sustaining attention on a task or activity.
10. Mood changes: Fluctuations in emotional state, such as depression, anxiety, or euphoria.
11. Psychosis: A severe mental disorder characterized by detachment from reality, hallucinations, and disorganized thinking or behavior.
12. Repetitive behaviors: Engaging in repetitive actions or movements, often associated with certain developmental disorders or neurological conditions.
13. Social withdrawal: Avoidance of social interactions or activities, often indicative of depression, anxiety, or other mental health concerns.
14. Thought disturbances: Disorganized or disrupted thinking patterns, such as racing thoughts, tangential thinking, or loose associations between ideas.

Behavioral symptoms can be caused by various factors, including medical conditions (such as infections, brain injuries, or neurodegenerative diseases), mental health disorders (such as depression, anxiety, bipolar disorder, or schizophrenia), substance abuse, and environmental factors (such as stress or trauma). Accurate assessment and diagnosis are crucial for determining appropriate treatment interventions.

An allele is a variant form of a gene that is located at a specific position on a specific chromosome. Alleles are alternative forms of the same gene that arise by mutation and are found at the same locus or position on homologous chromosomes.

Each person typically inherits two copies of each gene, one from each parent. If the two alleles are identical, a person is said to be homozygous for that trait. If the alleles are different, the person is heterozygous.

For example, the ABO blood group system has three alleles, A, B, and O, which determine a person's blood type. If a person inherits two A alleles, they will have type A blood; if they inherit one A and one B allele, they will have type AB blood; if they inherit two B alleles, they will have type B blood; and if they inherit two O alleles, they will have type O blood.

Alleles can also influence traits such as eye color, hair color, height, and other physical characteristics. Some alleles are dominant, meaning that only one copy of the allele is needed to express the trait, while others are recessive, meaning that two copies of the allele are needed to express the trait.

Language development refers to the process by which children acquire the ability to understand and communicate through spoken, written, or signed language. This complex process involves various components including phonology (sound system), semantics (meaning of words and sentences), syntax (sentence structure), and pragmatics (social use of language). Language development begins in infancy with cooing and babbling and continues through early childhood and beyond, with most children developing basic conversational skills by the age of 4-5 years. However, language development can continue into adolescence and even adulthood as individuals learn new languages or acquire more advanced linguistic skills. Factors that can influence language development include genetics, environment, cognition, and social interactions.

Dendrites are the branched projections of a neuron that receive and process signals from other neurons. They are typically short and highly branching, increasing the surface area for receiving incoming signals. Dendrites are covered in small protrusions called dendritic spines, which can form connections with the axon terminals of other neurons through chemical synapses. The structure and function of dendrites play a critical role in the integration and processing of information in the nervous system.

Southern blotting is a type of membrane-based blotting technique that is used in molecular biology to detect and locate specific DNA sequences within a DNA sample. This technique is named after its inventor, Edward M. Southern.

In Southern blotting, the DNA sample is first digested with one or more restriction enzymes, which cut the DNA at specific recognition sites. The resulting DNA fragments are then separated based on their size by gel electrophoresis. After separation, the DNA fragments are denatured to convert them into single-stranded DNA and transferred onto a nitrocellulose or nylon membrane.

Once the DNA has been transferred to the membrane, it is hybridized with a labeled probe that is complementary to the sequence of interest. The probe can be labeled with radioactive isotopes, fluorescent dyes, or chemiluminescent compounds. After hybridization, the membrane is washed to remove any unbound probe and then exposed to X-ray film (in the case of radioactive probes) or scanned (in the case of non-radioactive probes) to detect the location of the labeled probe on the membrane.

The position of the labeled probe on the membrane corresponds to the location of the specific DNA sequence within the original DNA sample. Southern blotting is a powerful tool for identifying and characterizing specific DNA sequences, such as those associated with genetic diseases or gene regulation.

Metabolic syndrome, also known as Syndrome X, is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes. It is not a single disease but a group of risk factors that often co-occur. According to the American Heart Association and the National Heart, Lung, and Blood Institute, a person has metabolic syndrome if they have any three of the following five conditions:

1. Abdominal obesity (waist circumference of 40 inches or more in men, and 35 inches or more in women)
2. Triglyceride level of 150 milligrams per deciliter of blood (mg/dL) or greater
3. HDL cholesterol level of less than 40 mg/dL in men or less than 50 mg/dL in women
4. Systolic blood pressure of 130 millimeters of mercury (mmHg) or greater, or diastolic blood pressure of 85 mmHg or greater
5. Fasting glucose level of 100 mg/dL or greater

Metabolic syndrome is thought to be caused by a combination of genetic and lifestyle factors, such as physical inactivity and a diet high in refined carbohydrates and unhealthy fats. Treatment typically involves making lifestyle changes, such as eating a healthy diet, getting regular exercise, and losing weight if necessary. In some cases, medication may also be needed to manage individual components of the syndrome, such as high blood pressure or high cholesterol.

The Stanford-Binet Test is a widely used, individually administered intelligence test that was revised from the original Binet-Simon Scale by Lewis Terman at Stanford University in 1916. It is designed to measure various cognitive abilities and intelligence across a broad age range, from early childhood to adulthood. The test assesses five factors of cognitive ability: fluid reasoning, knowledge, quantitative reasoning, visual-spatial processing, and working memory.

The Stanford-Binet Test consists of several subtests that measure different skills and abilities. It yields a composite score, called the Intelligence Quotient (IQ), which is a ratio of mental age to chronological age, multiplied by 100. The test also provides detailed information about an individual's strengths and weaknesses in various areas of cognitive functioning.

Over the years, the Stanford-Binet Test has undergone several revisions to improve its psychometric properties, update its content, and reflect current theories of intelligence. The most recent version, the Stanford-Binet Fifth Edition (SB5), was published in 2003 and includes updated norms, a broader age range (2-85+ years), and a more comprehensive assessment of cognitive abilities.

The Stanford-Binet Test is used for various purposes, including identifying individuals who may have intellectual disabilities or giftedness, educational planning, career counseling, and research. It is considered a reliable and valid measure of intelligence, but like all psychological tests, it should be administered and interpreted by trained professionals who are aware of its limitations and potential sources of bias.

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

A chromosome is a thread-like structure that contains genetic material, made up of DNA and proteins, in the nucleus of a cell. In humans, there are 23 pairs of chromosomes, for a total of 46 chromosomes, in each cell of the body, with the exception of the sperm and egg cells which contain only 23 chromosomes.

The X chromosome is one of the two sex-determining chromosomes in humans. Females typically have two X chromosomes (XX), while males have one X and one Y chromosome (XY). The X chromosome contains hundreds of genes that are responsible for various functions in the body, including some related to sexual development and reproduction.

Humans inherit one X chromosome from their mother and either an X or a Y chromosome from their father. In females, one of the two X chromosomes is randomly inactivated during embryonic development, resulting in each cell having only one active X chromosome. This process, known as X-inactivation, helps to ensure that females have roughly equal levels of gene expression from the X chromosome, despite having two copies.

Abnormalities in the number or structure of the X chromosome can lead to various genetic disorders, such as Turner syndrome (X0), Klinefelter syndrome (XXY), and fragile X syndrome (an X-linked disorder caused by a mutation in the FMR1 gene).

Prenatal diagnosis is the medical testing of fetuses, embryos, or pregnant women to detect the presence or absence of certain genetic disorders or birth defects. These tests can be performed through various methods such as chorionic villus sampling (CVS), amniocentesis, or ultrasound. The goal of prenatal diagnosis is to provide early information about the health of the fetus so that parents and healthcare providers can make informed decisions about pregnancy management and newborn care. It allows for early intervention, treatment, or planning for the child's needs after birth.

Deoxyribonucleic acid (DNA) is the genetic material present in the cells of organisms where it is responsible for the storage and transmission of hereditary information. DNA is a long molecule that consists of two strands coiled together to form a double helix. Each strand is made up of a series of four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - that are linked together by phosphate and sugar groups. The sequence of these bases along the length of the molecule encodes genetic information, with A always pairing with T and C always pairing with G. This base-pairing allows for the replication and transcription of DNA, which are essential processes in the functioning and reproduction of all living organisms.

Repetitive sequences in nucleic acid refer to repeated stretches of DNA or RNA nucleotide bases that are present in a genome. These sequences can vary in length and can be arranged in different patterns such as direct repeats, inverted repeats, or tandem repeats. In some cases, these repetitive sequences do not code for proteins and are often found in non-coding regions of the genome. They can play a role in genetic instability, regulation of gene expression, and evolutionary processes. However, certain types of repeat expansions have been associated with various neurodegenerative disorders and other human diseases.

"What is Fragile-X syndrome?". @yourgenome · Science website. Retrieved 2023-07-15. "What are the symptoms of Fragile X syndrome ... ISBN 978-1-4160-4570-0. Section on fragile X syndrome[page needed] Nichols C, Nichols D (1 June 2019). "Fragile X Syndrome: ... Fragile X syndrome is a genetic disorder which occurs as a result of a mutation of the Fragile X Messenger Ribonucleoprotein 1 ... Cytogenetic analysis for fragile X syndrome was first available in the late 1970s when diagnosis of the syndrome and carrier ...
... (WFFS) is a genetic disorder seen in horses. At first it was studied in Warmblood horses, but ... "Warmblood Fragile Foal Syndrome Type 1". University of California/UCDavis. v t e (Articles with short description, Short ... "Skin malformations in a neonatal foal tested homozygous positive for Warmblood Fragile Foal Syndrome". BMC Veterinary Research ... WFFS is a genetic defect of connective tissue and foals born with it have hyper-extendible, abnormally thin, fragile skin that ...
Costello syndrome, Gorlin syndrome, (also known as Basal Cell Nevus Syndrome) and cardiofaciocutaneous syndrome; Fragile X ... Behmel syndrome Sotos syndrome Sturge-Weber syndrome Weaver syndrome Wiedemann-Rautenstrauch syndrome 3C syndrome Glutaric ... Joubert syndrome Keipert syndrome Legius syndrome LEOPARD syndrome Lethal congenital contracture syndrome MASA syndrome ... Acrocallosal syndrome Apert syndrome Bannayan-Riley-Ruvalcaba syndrome Cardiofaciocutaneous syndrome Chromosome 14 - maternal ...
Fragile X syndrome, a trinucleotide repeat disorder, is a condition in which premutations may be present in the parents of ... "fragile X syndrome". Genetics Home Reference. April 2012. Archived from the original on 9 October 2016. Retrieved 7 October ...
A Novel Pharmacologic Approach to Treating Fragile X Syndrome. Gordon Research Conference in Fragile X and Autism-related ... Fragile X syndrome (FXS) is a genetic disorder that is the most common single gene cause of intellectual disability and autism ... Dölen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF (December 2007). "Correction of fragile X syndrome in ... Garber KB, Visootsak J, Warren ST (June 2008). "Fragile X syndrome". European Journal of Human Genetics. 16 (6): 666-72. doi: ...
The second DNA-triplet repeat disease, fragile X-E syndrome, was also identified on the X chromosome, but was found to be the ... In some of these diseases, such as Fragile X syndrome, the pathology is caused by lack of the normal function of the protein ... The first trinucleotide repeat disease to be identified was fragile X syndrome, which has since been mapped to the long arm of ... "Fragile XE syndrome". Genetic and Rare Diseases Information Center (GARD). Archived from the original on 9 March 2013. ...
Fragile X syndrome is caused by the expansion of the DNA sequence CCG in the FMR1 gene on the X chromosome. This gene produces ... In the case of Fragile X syndrome the repeated sequence makes the gene unstable and therefore silences the gene FMR1. Because ... September 2017). "Fragile X syndrome". Nature Reviews. Disease Primers. 3 (1): 17065. doi:10.1038/nrdp.2017.65. PMID 28960184. ... The two genes don't encode for proteins unlike other disorders like Huntington's disease or Fragile X syndrome. It has been ...
The FRAXA site is perhaps most famous for its role in Fragile X syndrome, but fragile sites are clinically implicated in many ... Clinically, the most important rare fragile site is FRAXA in the FMR1 gene, which is associated with the fragile X syndrome, ... Fragile sites have also been implicated in a variety of syndromes (for a review, see ). For example, breakage at or near the ... Casper, AM; Durkin, SG; Arlt, MF; Glover, TW (Oct 2004). "Chromosomal instability at common fragile sites in Seckel syndrome". ...
Fragile X syndrome affects about two to five percent of people with ASD. If one child has Fragile X, there is a 50% chance that ... "Autism and Fragile X Syndrome". National Fragile X Foundation. Archived from the original on 3 September 2015. Retrieved 3 ... Fragile X syndrome is the most common inherited form of intellectual disability. It was so named because one part of the X ... Turner syndrome is an intersex condition wherein a person is born phenotypically female but with only one X chromosome or with ...
... such as fragile x syndrome. Approximately 20-28% of women with an FMR1 premutation (55-200 CGG repeats) experience fragile x ... "Facts about Primary Ovarian Insufficiency (POI)". The National Fragile X Foundation. Archived from the original on 2008-11-06. ... Seow KM, Juan CC, Hwang JL, Ho LT (January 2008). "Laparoscopic surgery in polycystic ovary syndrome: reproductive and ... Check JH (2006). "Pharmacological options in resistent[sic] ovary syndrome and premature ovarian failure". Clinical and ...
... for Fragile X SyndromeFragile X Research - FRAXA Research Foundation". 2014-04-24. "AFQ056 drug improves symptoms in Fragile ... Otherwise, it would have been the first drug to treat the underlying disorder instead of the symptoms of fragile X syndrome. ... Mavoglurant (developmental code name AFQ-056) is an experimental drug candidate for the treatment of fragile X syndrome and ... Phase IIb/III dose finding and evaluation trials for fragile X-syndrome were discontinued by the end of 2014. ...
A link has been suggested between microchromosome presence and certain genetic disorders like Down syndrome and fragile X ... "Fragile X syndrome with extra microchromosome". Clinical Genetics. 45 (4): 186-9. doi:10.1111/j.1399-0004.1994.tb04020.x. PMID ... Ramos, C; Rivera, L; Benitez, J; Tejedor, E; Sanchez-Cascos, A (1979). "Recurrence of Down's syndrome associated with ... syndrome. The smallest chromosome in humans is normally chromosome 21, which is 47 Mb. Minichromosome Ohno, Susumu; Christian, ...
"Minocycline Promising in Fragile X Syndrome". medscape.com. Retrieved 1 July 2016. Hagerman, Randi J., et al. "Fragile-X- ... "Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)." Brain 129.1 (2006): 243-255. "Randi J. Hagerman, M.D. ... Along with her husband Paul Hagerman, she discovered the Fragile X-associated tremor/ataxia syndrome (FXTAS), a neurological ... Randi Hagerman: Fragile X Conditions expert". blog.sfgate.com. 30 January 2013. Retrieved 1 July 2016. Megan Brooks (7 ...
Heilman KJ, Harden E., Zageris D, Berry-Kravis E, Porges SW (2011). Autonomic regulation in Fragile X Syndrome. Developmental ...
Cantore's children have Fragile X syndrome. Cantore does charitable work for FRAXA, the Fragile X Research Foundation, and the ...
"Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome". American ... Though the greatest risks for female carriers of an FMR1 premuation are developing POI and having a child Fragile X Syndrome, ... An additional challenge for women with an FMR1 premutation is determining the risk for having a child with Fragile X Syndrome. ... October 2007). "Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines". Movement ...
... as seen in the fragile X mental retardation gene 1 (FMR1) gene and Fragile X Syndrome. The C9orf72 gene codes for the protein ... Specifically, Fragile X Syndrome is caused by an increase from 50 to over 200 CGG repeats within exon 13 of the FMR1 gene. This ... Mutations of this gene can cause the development of Fragile X Syndrome, autism, and other neurological disorders. ... Kamath-Loeb A, Loeb LA, Fry M (2012). Cotterill S (ed.). "The Werner syndrome protein is distinguished from the Bloom syndrome ...
Dölen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF (December 2007). "Correction of fragile X syndrome in ... Most recently, Group I mGluRs, have been implicated in the pathogenesis of Fragile X, a type of autism, and a number of studies ... Dölen G, Carpenter RL, Ocain TD, Bear MF (July 2010). "Mechanism-based approaches to treating fragile X". Pharmacology & ...
"Abbeduto receives grant to study language acquisition in fragile X syndrome and Down syndrome". www.ucdmc.ucdavis.edu. ... Down syndrome, or Fragile X syndrome". American Journal on Mental Retardation. 109 (3): 237-254. doi:10.1352/0895-8017(2004)109 ... including Fragile X syndrome, autism spectrum disorder, and Down syndrome, and factors that influence their linguistic ... He has contributed to research on Fragile X syndrome, not only by focusing on communication and language development, but also ...
Randi Jenssen Hagerman and Paul J. Hagerman (2002). Fragile X Syndrome: Diagnosis, Treatment, and Research. Johns Hopkins ...
Diagnosis of the fragile X syndrome. Fellow, American Association for the Advancement of Science (2014) Barbara Bowman ... Their findings in FMR1 explained the unusual inheritance in Fragile X syndrome and provided the principles for all subsequent ... Nelson's contributions have led to the description of Lowe syndrome, and the identification of FMR2 for FRAXE syndrome. ... mouse and fly reference sequences and was a co-discoverer of the mutation that causes Fragile X syndrome as an expansion of a ...
... fragile X syndrome. Randi J. Hagerman and Paul J. Hagerman have been studying genotype-phenotype correlations in fragile X and ... Hagerman, R.J.; Hagerman, P.J. (2002). Fragile X Syndrome: Diagnosis, Treatment, and Research. Johns Hopkins Series in Contem. ... fragile X syndrome, and other neurodevelopmental disorders. The director of the MIND institute is Dr. Leonard Abbeduto. Parents ... and generalized brain atrophy in male carriers of fragile X". Neurology. Ovid Technologies (Wolters Kluwer Health). 57 (1): 127 ...
Implications for Fragile X mental retardation syndrome". J. Biol. Chem. 276 (6): 4357-64. doi:10.1074/jbc.M009629200. PMID ...
Dölen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF (2007). "Correction of fragile X syndrome in mice". ... The role of group I metabotropic glutamate receptors (mGluR) in the pathogenesis of fragile X syndrome, the most common ... Bear MF, Dölen G, Osterweil E, Nagarajan N (2008). "Fragile X: translation in action". Neuropsychopharmacology. 33 (1): 84-7. ... and a correlation between reduced MNS activity and severity of the syndrome in children with ASD. However, individuals with ...
His sons both have fragile X syndrome. The family resides in Abbotsford, British Columbia, Canada. Vineyard Music albums ...
Fragile X syndrome: A 2015 Cochrane review of ALCAR in fragile X syndrome found only two placebo-controlled trials, each of low ... Rueda JR, Guillén V, Ballesteros J, Tejada MI, Solà I (May 2015). "L-acetylcarnitine for treating fragile X syndrome". The ...
"Imposter Syndrome - EP by GRACEY on Apple Music". Apple Music. Retrieved 9 February 2021. "Fragile - EP by GRACEY on Apple ...
Implications for Fragile X mental retardation syndrome". The Journal of Biological Chemistry. 276 (6): 4357-64. doi:10.1074/jbc ... ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia". ...
... boys with Van Wyk Grumbach Syndrome (VWGS), and boys with fragile X syndrome (FXS). When macroorchidism is considered, the ... The condition is commonly inherited in connection with fragile X syndrome (FXS), which is also the second most common genetic ... Macroorchidism is present in more than 80 - 90% of postpubertal males with fragile X syndrome. A research study was done in ... Because macroorchidism is associated with fragile X syndrome patients, the signs in patients with FXS is similar in patients ...
"Dysregulation of mTOR signaling in fragile X syndrome". The Journal of Neuroscience. 30 (2): 694-702. doi:10.1523/JNEUROSCI. ...
"What is Fragile-X syndrome?". @yourgenome · Science website. Retrieved 2023-07-15. "What are the symptoms of Fragile X syndrome ... ISBN 978-1-4160-4570-0. Section on fragile X syndrome[page needed] Nichols C, Nichols D (1 June 2019). "Fragile X Syndrome: ... Fragile X syndrome is a genetic disorder which occurs as a result of a mutation of the Fragile X Messenger Ribonucleoprotein 1 ... Cytogenetic analysis for fragile X syndrome was first available in the late 1970s when diagnosis of the syndrome and carrier ...
Fragile X syndrome is caused by a change in a gene and is passed from parent to child. Learn about symptoms and effects of this ... Features of Fragile X Syndrome (National Fragile X Foundation) * What Are the Symptoms of Fragile X Syndrome? (Eunice Kennedy ... Fragile X Syndrome and Autism (National Fragile X Foundation) * Fragile X Syndrome: Other FAQs (Eunice Kennedy Shriver National ... Learning about Fragile X Syndrome (National Human Genome Research Institute) * What Is Fragile X Syndrome (FXS)? (Centers for ...
View scientific articles about Fragile X Syndrome (FXS). ... homeFragile X Syndrome Home. *What is Fragile X Syndrome?plus ... More Fragile X Syndrome Articles. Visit PubMed (nih.gov) and use the search term "fragile X" to find additional articles on ... Key Findings: Advancing Treatment and Care for Fragile X Syndrome. Fragile X-associated disorders (FXD) are among the most ... Fragile X syndrome (FXS): Learning what families need, one person at a time.. FXS is the most common cause of inherited ...
... also termed Martin-Bell syndrome or marker X syndrome, is the most common cause of inherited mental retardation, intellectual ... encoded search term (Fragile X Syndrome) and Fragile X Syndrome What to Read Next on Medscape ... The fragile X syndrome: no evidence for any recent mutations. J Med Genet. 1993 Feb. 30(2):94-6. [QxMD MEDLINE Link]. [Full ... Fragile X Syndrome Differential Diagnoses. Updated: Aug 15, 2022 * Author: Jennifer A Jewell, MD, MS; Chief Editor: Maria ...
... also termed Martin-Bell syndrome or marker X syndrome, is the most common cause of inherited mental retardation, intellectual ... Signs and symptoms of fragile X syndrome. Patients with fragile X syndrome present with problems in the following areas [2] :. ... Fragile X syndrome, also termed Martin-Bell syndrome or marker X syndrome, is the most common cause of inherited mental ... Fragile X syndrome, also termed Martin-Bell syndrome or marker X syndrome, is the most common cause of inherited mental ...
... is caused by a lack of the fragile X mental retardation protein (FMRP); FMRP deficiency in neurons of patients with FXS causes ... Fragile X syndrome (FXS) is caused by a lack of the fragile X mental retardation protein (FMRP); FMRP deficiency in neurons of ... Potential therapeutic interventions for fragile X syndrome Trends Mol Med. 2010 Nov;16(11):516-27. doi: 10.1016/j.molmed. ...
Two studies clarifying the role of FMRP in mRNA translation in fragile X syndrome By Azra Jaferi ... degradation is identified as a new cellular pathology and a potential target for therapeutic intervention in fragile X syndrome ... Electroretinogram activity and peripheral FMRP levels: Correlate biomarkers for fragile X spectrum disorders ...
Fragile X syndrome is an inherited disorder associated with mental retardation and a particular appearance. It is caused by an ... Fragile X Syndrome December 21, 2018 What Is It?. Fragile X syndrome is an inherited disorder associated with mental ... In people with fragile X, a particular section of the DNA code - CGG - is "fragile" and gets repeated an unusually large number ...
How are basic science findings being translated into treatments for patients with neurodevelopment disorders, like Fragile X ... Fragile X syndrome is one of the most common inherited causes of intellectual disability, right below Down syndrome. ... Fragile X syndrome is one of the most common inherited causes of intellectual disability, right below Down syndrome. How are ... But what is Fragile X syndrome, and what other research has been conducted around this neurodevelopmental disorder? ...
As the majority of patients with Fragile X Syndrome also display autism-like symptoms, the findings offer hope for treating ... clearer understanding of how mutations in a single gene can produce the complex cognitive deficits characteristic of Fragile X ... Syndrome, the most common inherited form of intellectual disability. ... Workings of brain protein suggest therapies for Fragile X Syndrome and autism. Date:. July 21, 2011. Source:. Cell Press. ...
Fragile X syndrome (FXS) is the most common hereditary form of mental retardation. Many children with FXS also suffer from ... Fragile X syndrome (FXS) is the most common hereditary form of mental retardation. Many children with FXS also suffer from ... ADHD Treatment Found for Children with Fragile X Syndrome. February 19, 2008. ScienceBlog.com ...
ASD Diagnosis in Fragile X Syndrome. We are excited to share journal publications like this one resulting from FORWARD data. ... Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome. By Amie Milunovich,2022-06- ... There are many more papers currently in development, and the future for Fragile X syndrome research is bright as more data is ... Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome. By Amie Milunovich,2023- ...
New York, NY: The use of CBD products provides symptom relief to pediatric patients with Fragile X Syndrome (FXS), according to ... Survey: Caregivers Report That CBD Improves Symptoms of Fragile X Syndrome. * by NORML ... Home,News,Survey: Caregivers Report That CBD Improves Symptoms of Fragile X Syndrome ... Full text of the study, "Parent and caregiver perspectives toward cannabidiol as a treatment for Fragile X Syndrome," appears ...
Researchers used AI to analyze horse conformation and detected differences between fragile foal syndrome carriers and ... Researchers used AI to analyze horse conformation and detected differences between fragile foal syndrome carriers and ... Fragile foal syndrome (FFS) is a genetic variant in horses that leads to defects in the connective tissues, including very thin ... Horses with fragile foal syndrome often do not live long after birth. , Photo: iStock ...
The syndrome affects both males and females, although males are typically more severely affected. In addition to learning ... Fragile X syndrome is the leading inherited cause of intellectual disability, as well as the source of many cases of learning ... difficulties, children with fragile X often suffer from hyperactivity, social anxiety, hypersensitivity to… ... Fragile X Syndrome: Waisman Center Activities Fragile X Syndrome: Waisman Center Activities. Fragile X syndrome is the leading ...
Mothers and their sons age 18-24 months with Fragile X syndrome are needed for a study on supporting early language development ... Developing the Fragile X Syndrome-Health Index (FXS-HI): A Caregiver-Reported Outcome Measure. The Center of Health and ... Research Study: Power of the Point - Predictors of Early Language Development in Fragile X Syndrome. The Development in ... Mothers and their sons or daughters ages 18- to 36-months with a diagnosis of full mutation Fragile X syndrome may be eligible ...
Fragile X Syndrome Testing (FRX). Download Printer-Friendly PDF Information for Ordering. + - Acceptable Specimen Types Click ... Fragile X syndrome is one of the most common genetic causes of mental retardation in males with an estimated incidence of 1: ... Fragile X is usually caused by a trinucleotide expansion in the FMR1 gene on the X chromosome. Normal individuals have ,40 CGG ... Males affected with Fragile X typically have moderate mental retardation, and can present with characteristic physical features ...
... gel product Zygel for Fragile X syndrome and other rare neuropsychi ...
2are more likely to have Fragile X Syndrome and usually have more severe symptoms thanBOYSGIRLSWhat causes Fragile X Syndrome ? ... Fragile X SyndromeWhat is Fragile X Syndrome (FXS)?An inherited genetic disorder that causes a range of developmental problems ... the more serious the symptoms areHow is Fragile X inherited?A mother who carries Fragile X has a 50% chance of passing the ... carriers but they do not have FXSbecause boys receive only a Y chromosome from their fathersHow common is Fragile X Syndrome in ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Centers RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...
Oostra BA, Jacky PB, Brown WT, Rousseau F. Guidelines for the diagnosis of fragile X syndrome. National Fragile X Foundation. J ... Key Words: Fragile X syndrome, Intellectual disability, Fragile X mental retardation 1, CGG repeat, Indonesia ... Table 1 Fragile X mental retardation 1 gene analysis of index fragile X syndrome subjects. ... Fragile X syndrome: diagnostic and carrier testing. Genet Med. 2005;7:584-587. [PubMed] [DOI] [Cited in This Article: ] [Cited ...
... causes mild to severe intellectual disability. It affects both males and females, but females usually have ...
A randomized crossover study of BPN14770 in adult males with fragile X syndrome shows significant cognitive improvement in ... would improve cognitive function and behavioral outcomes in patients with fragile X syndrome (FXS). This phase 2 trial was a 24 ... Mavoglurant in fragile X syndrome: results of two randomized, double-blind, placebo-controlled trials. Sci. Transl. Med. 8, ... Berry-Kravis, E.M., Harnett, M.D., Reines, S.A. et al. Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a ...
What is Fragile X?*About Fragile X Syndrome*What Is Fragile X Syndrome? ... FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome Accelerating Fragile X Research for Effective Treatments ... Taurine and Somatostatin as Potential Treatments for Fragile X Syndrome: A Unifying Neuro-Endocrine Hypothesis FRAXA Research ... Copyright © 2023 FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome. FRAXA Research Foundation is a registered ...
Home » Mechanism of Fragile X Syndrome Revealed. Mechanism of Fragile X Syndrome Revealed. Fragile X syndrome (FXS) is caused ... The DNA Replication Program Is Altered at the FMR1 Locus in Fragile X Embryonic Stem Cells. Mol Cell. 2014 Jan 9; 53(1):19-31. ... by expansion of the CGG trinucleotide repeat in the Fragile X Mental Retardation gene, FMR1. FXS results in intellectual ...
What is Fragile X?*About Fragile X Syndrome*What Is Fragile X Syndrome? ... FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome Accelerating Fragile X Research for Effective Treatments ... Hwan Kim at Duke University bred the standard mouse model of Fragile X syndrome to their lines of mice that express reduced ... Copyright © 2023 FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome. FRAXA Research Foundation is a registered ...
An experimental medicine seems to ease symptoms of Fragile X syndrome, a genetic disorder that is the most common inherited ... Fragile X syndrome is a genetic disorder that affects about 1 in 4,000 males and a smaller proportion of females. It is the ... Fragile X syndrome involves changes in the X chromosome, as pictured in the four columns of chromosomes starting on the left. ... An Alzheimers Drug May Boost Cognition In People With Fragile X Syndrome ...
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, ... Fragile X Tremor Ataxia Syndrome (FXTAS) is usually found in older adults, who often have grandchildren afflicted with Fragile ... Researchers find a way to block neurodegeneration in an adult form of Fragile X syndrome. Dec 16, 2010 04:32 PM. By ... Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, ...
Homozygosity for the PLOD1 variant causes an Ehler-Danlos-like syndrome, which has to date only been reported in warmblood ... Warmblood fragile foal syndrome (WFFS) is an autosomal recessive disorder caused by a single nucleotide variant in the ... The second EDS-like syndrome was named Warmblood fragile foal syndrome type 1 (WFFS) because it was initially identified in ... Bellone, R.R.; Ocampo, N.R.; Hughes, S.S.; Le, V.; Arthur, R.; Finno, C.J.; Penedo, M.C.T. Warmblood fragile foal syndrome type ...
OV101 has previously been granted Orphan Drug status for Fragile X and Fast Track status for Angelman syndrome. ... A Phase 2 trial of OV101 in males with Fragile X syndrome aged 13 to 22 is planned for later in 2018. ... for the treatment of Fragile X syndrome. Fragile X is a rare inherited syndrome of intellectual disability and autism. ... OV101 has previously been granted Orphan Drug status for Fragile X and Fast Track status for Angelman syndrome.. ...
  • The National Fragile X Foundation supports families living with Fragile X through community, awareness and education, and research. (fragilex.org)
  • Investigators affiliated with the Icahn School of Medicine at Mount Sinai, New York and with the National Fragile X Foundation in McLean, Virginia surveyed the parents and caregivers of individuals with FXS who were receiving or had received CBD. (norml.org)
  • In addition, diagnosis will allow for families to be a part of the National Fragile X Foundation (NFXF) Community Support Network. (hhs.gov)
  • For more information, see the National Fragile X Foundation . (msdmanuals.com)
  • Fragile X syndrome (FXS) is a genetic disorder characterized by mild-to-moderate intellectual disability. (wikipedia.org)
  • Fragile X syndrome co-occurs with autism in many cases and is a suspected genetic cause of the autism in these cases. (wikipedia.org)
  • A genetic blood test can diagnose Fragile X. There is no cure. (medlineplus.gov)
  • Del Hoyo Soriano L, Thurman AJ, Harvey DJ, Ted Brown W, Abbeduto L. Genetic and maternal predictors of cognitive and behavioral trajectories in females with fragile X syndrome. (medscape.com)
  • The criterion standard diagnostic test for fragile X syndrome involves molecular genetic techniques that detect the FMR1 gene. (medscape.com)
  • Fragile foal syndrome (FFS) is a genetic variant in horses that leads to defects in the connective tissues, including very thin skin, a deformed spine, open body cavities, and sores on the body in homozygous (meaning they have two copies of it) animals and can be fatal. (thehorse.com)
  • Fragile X is caused by a repetitive genetic error on the long arm of the X chromosome. (wisc.edu)
  • Fragile X syndrome is one of the most common genetic causes of mental retardation in males with an estimated incidence of 1:4000-6250 in males. (uab.edu)
  • Fragile X syndrome is a genetic disorder that affects about 1 in 4,000 males and a smaller proportion of females. (wunc.org)
  • Fragile X syndrome is a genetic disorder that affects both males and females but males are more severely affected than females. (omicsonline.org)
  • Fragile X syndrome is a genetic disorder that affects both males and females but males are more severely affected compared to females. (omicsonline.org)
  • Fragile X syndrome is an inherited genetic condition that causes intellectual and developmental disabilities and is commonly associated with autism. (pediastaff.com)
  • Although hypermobile Ehlers-Danlos syndrome (hEDS) is the most common type of EDS, its genetic etiology is unclear. (bmj.com)
  • Fragile X is an inherited genetic disorder affecting the X chromosome in both males and females. (hhs.gov)
  • With the help of a genetic counselor, the diagnosis of fragile X can lead to multiple immediate and extended family members learning they may have or are at-risk for developing a fragile X disorder. (hhs.gov)
  • To review, retrospectively, the genetic services for FXS and other FMR-1 -related disorders - including fragile X-associated tremor/ataxia syndrome (FXTAS) and FMR-1 -related primary ovarian insufficiency (POI) - at the Division of Human Genetics, Johannesburg, for diagnostic, carrier and prenatal genetic testing. (samj.org.za)
  • Fragile X syndrome is a genetic abnormality on the X chromosome that leads to intellectual disability and behavior problems. (msdmanuals.com)
  • Fragile X syndrome: genetic localisation by linkage mapping of two microsatellite repeats FRAXAC1 and FRAXAC2 which immediately flank the fragile site. (cnrs.fr)
  • Past research has shown that the disruption of FMRP is responsible for Fragile X syndrome, which is the most commonly known genetic cause of autism. (bbrfoundation.org)
  • The fragile X syndrome is a genetic disorder, identified microscopically by a constriction called fragile site on the long arm of chromosome X, considered the main inherited cause of mental disability associated with several neurological disorders. (bvsalud.org)
  • This article deals with the links between psychoanalysis and genetic medicine in regard to the fragile X syndrome (FXS), and it aims to be accessible to psychologists, psychoanalysts and doctors. (bvsalud.org)
  • 1. Subject has Fragile X syndrome with a molecular genetic confirmation of the full FMR1 mutation or mosaicism. (who.int)
  • It helps regulate GENETIC TRANSLATION in NEURONS and is absent or under-expressed in FRAGILE X SYNDROME. (bvsalud.org)
  • Aside from intellectual disability, prominent characteristics of the syndrome may include an elongated face, large or protruding ears, flat feet, larger testes (macroorchidism), and low muscle tone. (wikipedia.org)
  • In June of 2017, a supplement to the journal Pediatrics focused on fragile X-associated disorders, some of the most common inherited causes of intellectual disability. (cdc.gov)
  • Fragile X-associated disorders (FXD) are among the most common inherited causes of intellectual disability or problems with learning, thinking, reasoning, or remembering. (cdc.gov)
  • Researchers at the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), along with RTI International, recently published findings from a study on the financial expense of caring for a child living with fragile X syndrome as compared to caring for a child with autism spectrum disorder (ASD), a child with intellectual disability (ID), or a child with both ASD and ID. (cdc.gov)
  • Fragile X syndrome, also termed Martin-Bell syndrome or marker X syndrome, is the most common cause of inherited mental retardation, intellectual disability, and autism and is the second most common cause of genetically associated mental deficiencies, after trisomy 21. (medscape.com)
  • Fragile X syndrome is one of the most common inherited causes of intellectual disability, right below Down syndrome. (psychiatrictimes.com)
  • Researchers now have a much clearer understanding of how mutations in a single gene can produce the complex cognitive deficits characteristic of Fragile X Syndrome, the most common inherited form of intellectual disability. (sciencedaily.com)
  • Fragile X syndrome is the leading inherited cause of intellectual disability, as well as the source of many cases of learning disabilities and autism. (wisc.edu)
  • Fragile X syndrome causes mild to severe intellectual disability. (stclair.org)
  • Fragile X is a rare inherited syndrome of intellectual disability and autism. (empr.com)
  • A learning technique that maximizes the brain's ability to make and store memories may help overcome cognitive issues seen in fragile X syndrome, a leading form of intellectual disability, according to UC Irvine neurobiologists. (pediastaff.com)
  • What is called the full mutation leads to fragile X syndrome (FXS), resulting in developmental delays and intellectual disability in almost all males and many females. (hhs.gov)
  • Fragile X syndrome (FXS), the most common inherited cause of intellectual disability (ID) worldwide, is caused by the expansion of a CGG repeat in the fragile X mental retardation gene ( FMR-1 ) gene. (samj.org.za)
  • Down Syndrome (Trisomy 21) Down syndrome is a chromosome disorder caused by an extra chromosome 21 that results in intellectual disability and physical abnormalities. (msdmanuals.com)
  • Of those with fragile X syndrome, prevalence of concurrent autism spectrum disorder (ASD) has been estimated to be between 15 and 60%, with the variation due to differences in diagnostic methods and the high frequency of autistic features in individuals with fragile X syndrome not meeting the DSM criteria for an ASD. (wikipedia.org)
  • After examining the child, I decided to do some investigations that settled my provisional diagnosis of Fragile X syndrome with Autism Spectrum Disorder (ASD). (omicsonline.org)
  • It is typically caused by an expansion of the CGG triplet repeat within the FMR1 (fragile X messenger ribonucleoprotein 1) gene on the X chromosome. (wikipedia.org)
  • AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. (medscape.com)
  • Fragile Females: Case Series of Epilepsy in Girls With FMR1 Disruption. (medscape.com)
  • Fragile X is usually caused by a trinucleotide expansion in the FMR1 gene on the X chromosome. (uab.edu)
  • Fragile X syndrome (FXS) is caused by expansion of the CGG trinucleotide repeat in the Fragile X Mental Retardation gene, FMR1 . (ny.gov)
  • The DNA Replication Program Is Altered at the FMR1 Locus in Fragile X Embryonic Stem Cells. (ny.gov)
  • Mutations occur in the FMR1 gene which can block expression of the Fragile X Mental Retardation Protein (FMRP), an important protein in GABA synthesis. (empr.com)
  • Fragile X is diagnosed using the FMR1 DNA test (sometimes called the fragile X DNA test). (hhs.gov)
  • Fragile X Syndrome is caused by the expansion or lengthening of the FMR1 gene on the X chromosome, known as a gene mutation. (cmcrc.com)
  • 200-trinucleotide repeat expansion in the 5′ untranslated region of the fragile X mental retardation 1 (FMR1) gene. (cogstate.com)
  • FXS occurs as a result Fmr1 gene hypermethylation, which leads to inactivation and loss of Fragile X Mental Retardation Protein (FMRP). (escholarship.org)
  • An alteration in the number of CGG triplets in the FMR1 gene causes Fragile X Syndrome, a hereditary disease with X-linked transmission. (personalgenomics.it)
  • Researchers from the Centers for Disease Control and Prevention (CDC) and other organizations present data on preventive services received by children and young adults with fragile X syndrome (FXS). (cdc.gov)
  • More than 30 fragile X specialty clinics exist in the U.S. to provide expert care and treatment recommendations to individuals and families living with fragile X. In addition, families that attend one of these clinics are invited to participate in a longitudinal research project known as FORWARD and funded by the Centers for Disease Control and Prevention. (hhs.gov)
  • A report in the July 22nd issue of the journal Cell , published by Cell Press, defines a set of messenger RNA (mRNA) molecules that the Fragile-X mental retardation protein (FMRP) binds in the brains of mice. (sciencedaily.com)
  • In premutation carriers, a possible connection between both conditions could be explained by a depletion of fragile X mental retardation protein (FMRP), a major regulatory protein for extracellular matrix (ECM) function. (bmj.com)
  • How are basic science findings being translated into treatments for patients with neurodevelopment disorders, like Fragile X syndrome? (psychiatrictimes.com)
  • This paper, published in the Journal of Autism and Developmental Disorders , addresses the difficulty of diagnosing autism in Fragile X syndrome . (fragilex.org)
  • Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. (nature.com)
  • This 95-page scientific plan outlines research goals and objectives on Fragile X syndrome and related disorders for the NIH Institutes. (nih.gov)
  • This 95-page scientific plan outlines research goals and objectives on Fragile X syndrome and related disorders for the NIH Institutes, including the NICHD, which support and conduct research related to Fragile X syndrome and its associated disorders. (nih.gov)
  • Carriers of what is referred to as the pre mutation are at risk for developing other disorders, primarily fragile X-associated tremor-ataxia syndrome (FXTAS), an adult-onset degenerative neurological condition, and fragile X-associated primary ovarian insufficiency (FXPOI), resulting in reproductive issues including early menopause. (hhs.gov)
  • This foundation has parent-led groups in almost all 50 states and links families to research projects that could potentially lead to better prevention and treatment of fragile X disorders. (hhs.gov)
  • Carpal tunnel syndrome (CTS), hand/wrist tendonitis, hand-arm vibration syndrome (HAVS), and other hand-arm system disorders have been associated with forceful hand actions in combination with awkward postures and repetitive motions. (cdc.gov)
  • Spath MA, Feuth TB, Smits AP, Yntema HG, Braat DD, Thomas CM. Predictors and risk model development for menopausal age in fragile X premutation carriers. (medscape.com)
  • 2004]. Evidence of early ovarian aging in Fragile X premutation carriers. (natural-fertility-prescription.com)
  • Advances in the treatment of fragile X syndrome. (medscape.com)
  • Ovid Therapeutics), a delta (δ)-selective GABA A receptor agonist, for the treatment of Fragile X syndrome. (empr.com)
  • Although there is no current curative treatment of Fragile X syndrome, there are many available therapeutic modalities that can be used to control its manifestations and improve the quality of life of its sufferers. (omicsonline.org)
  • A Phase 2 trial of OV101 in males with Fragile X syndrome aged 13 to 22 is planned for later in 2018. (empr.com)
  • Topline data from the company's Phase 2 STARS clinical trial investigating OV101 for the treatment of adults and adolescents with Angelman syndrome are expected in the second half of 2018. (empr.com)
  • With a $163,356 grant from FRAXA Research Foundation in 2010-12, Dr. Scott Soderling and Dr. Hwan Kim at Duke University bred the standard mouse model of Fragile X syndrome to their lines of mice that express reduced levels of several key proteins that modulate synaptic actin. (fraxa.org)
  • Fragile X syndrome tends to show more symptoms on affected males since females have another X chromosome which can compensate for the damaged one. (wikipedia.org)
  • This causes the symptoms of Fragile X. (medlineplus.gov)
  • People with only a small change in the gene might not show any signs of Fragile X. People with bigger changes can have severe symptoms. (medlineplus.gov)
  • What Are the Symptoms of Fragile X Syndrome? (medlineplus.gov)
  • As the majority of patients with Fragile X Syndrome also display autism-like symptoms, the findings offer hope for treating both conditions. (sciencedaily.com)
  • By understanding for the first time the direct targets of FMRP and its actions, we open up a whole world of potential avenues for therapies designed to make kids with Fragile X or autism better," said Robert Darnell, a Howard Hughes Medical Institute investigator at The Rockefeller University. (sciencedaily.com)
  • Their basic scientific discoveries suggest two different overall strategies for treating Fragile X Syndrome: by lowering the activity of particular proteins normally kept under wraps by FMRP or by replacing FMRP's ability to stall ribosomes. (sciencedaily.com)
  • Researchers at the Waisman Center at UW-Madison are recruiting adults with the Fragile X premutation for a study on language, executive function, and quality of life. (fragilex.org)
  • An experimental drug intended for Alzheimer's patients seems to improve both language and learning in adults with Fragile X syndrome. (wunc.org)
  • The Company has completed a Phase 1 safety study in adults and children who have Fragile X and Angelman syndrome, which proved successful. (empr.com)
  • Children and adults with the syndrome may have physical, intellectual, and behavior problems. (msdmanuals.com)
  • Sensory processing dysregulation is so common for children and adults living with Fragile X syndrome and it presents real challenges for behaviours and daily living. (fragilex.org.au)
  • Mothers and their sons or daughters ages 18- to 36-months with a diagnosis of full mutation Fragile X syndrome may be eligible to participate. (fragilex.org)
  • Fragile X carriers often have no visible signs of this mutation. (natural-fertility-prescription.com)
  • This test detects more than 99% of individuals (both males and females) with FXS (the full-mutation), as well as fragile X carriers (the premutation). (hhs.gov)
  • Lachiewicz AM, Dawson DV, Spiridigliozzi GA. Physical characteristics of young boys with fragile X syndrome: reasons for difficulties in making a diagnosis in young males. (medscape.com)
  • Bailey DB Jr, Raspa M, Bishop E, Holiday D. No change in the age of diagnosis for fragile x syndrome: findings from a national parent survey. (medscape.com)
  • Fragile X cases have more than 200 repeats of the trinucleotide CGG at a fragile locus of the X chromosome (Xq27.3) which affords the basis of the molecular diagnosis of the syndrome. (omicsonline.org)
  • Diagnosis will lead to specific fragile X evidence and consensus-based treatment including therapies, special education, counseling, and medication. (hhs.gov)
  • Celebrating everyone living with Fragile X and acknowledging the work being done to ensure early diagnosis and access to future treatments. (fragilex.org.au)
  • Fragile X syndrome: a possible articulation between psychoanalysis and genetics medicine? (bvsalud.org)
  • Individuals with fragile X syndrome (FXS) present with significant deficits in reading skills, but scant research exists to understand the characteristics of the reading delays or best practices for reading instruction with this population. (ed.gov)
  • Tetra Therapeutics recently announced positive results from its Phase II exploratory study in adult patients with Fragile X syndrome. (psychiatrictimes.com)
  • The use of CBD products provides symptom relief to pediatric patients with Fragile X Syndrome (FXS), according to survey responses provided by their parents and caregivers. (norml.org)
  • The goal of this study was to determine whether a phosphodiesterase-4D (PDE4D) allosteric inhibitor (BPN14770) would improve cognitive function and behavioral outcomes in patients with fragile X syndrome (FXS). (nature.com)
  • Our findings suggest an easily implemented, noninvasive strategy for treating an important component of the cognitive problems found in patients with fragile X syndrome. (pediastaff.com)
  • The aim of this study were analyzed physical and oral characteristics, medical problems and behavioral characteristics in patients with fragile X syndrome, and diffuse this syndrome among dentists. (bvsalud.org)
  • Fragile X syndrome involves changes in the X chromosome, as pictured in the four columns of chromosomes starting on the left. (wunc.org)
  • Later in 1969, Lubs [ 5 ] revealed a fragile site on the long arm of the X chromosome in males and some females of the same family . (omicsonline.org)
  • Down syndrome is caused by an extra chromosome 21. (msdmanuals.com)
  • Researchers used AI to analyze horse conformation and detected differences between fragile foal syndrome carriers and noncarriers that might have performance implications. (thehorse.com)
  • That is enough to change the lives of many people with Fragile X, says Mark Gurney , CEO of Tetra Therapeutics, developer of the medicine. (wunc.org)
  • Learn how CDC and the American Academy of Pediatrics join forces to debunk common myths about fragile X syndrome. (cdc.gov)
  • The syndrome affects both males and females, although males are typically more severely affected. (wisc.edu)
  • Help us learn more about how certain abilities, experiences, and biology affect language abilities in adulthood for both males and females with Fragile X syndrome. (sdparent.org)
  • Conservative estimates are that fragile X syndrome affects approximately 1 in 2500-4000 males and 1 in 7000-8000 females. (medscape.com)
  • The phenotype of fragile X syndrome is difficult to diagnose in prepubertal children. (medscape.com)
  • Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. (bvsalud.org)
  • Some individuals with fragile X syndrome also meet the diagnostic criteria for autism. (wikipedia.org)
  • The Waisman Center Clinics offer specialized diagnostic and assessment services to individuals who have, or are suspected of having a variety of developmental disabilities including fragile X syndrome. (wisc.edu)
  • Thus, we conclude that there are large variability among the characteristics expressed by individuals with the Fragile X syndrome, frequently these individuals have elongated face, prominent ears and mental retardation associated with oral problems such as malocclusion, atresic palate and enamel hypoplasia. (bvsalud.org)
  • Healthcare professionals should be aware of the family financial expense when addressing the complex needs of children living with fragile X syndrome (FXS). (cdc.gov)
  • Murphy MM. A review of mathematical learning disabilities in children with fragile X syndrome. (medscape.com)
  • De Smedt B, Swillen A, Verschaffel L, Ghesquiere P. Mathematical learning disabilities in children with 22q11.2 deletion syndrome: a review. (medscape.com)
  • Health supervision for children with fragile x syndrome. (medscape.com)
  • A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome. (medscape.com)
  • In addition to learning difficulties, children with fragile X often suffer from hyperactivity, social anxiety, hypersensitivity to sensory stimuli, and autism and autistic-like behaviors, all of which limit their social and academic progress, create challenges for teachers, and are a source of stress and uncertainty for their families. (wisc.edu)
  • Project WellCAST aims to understand how to best support caregivers of children with rare neurogenetic conditions, including Fragile X syndrome. (fragilex.org)
  • This study examined longitudinal trajectories of adaptive behavior in infants with fragile X syndrome (FXS), compared to typical development (TD) and infant siblings of children diagnosed with autism (ASIBs). (sc.edu)
  • As part of CDC's work to educate people about the condition and to celebrate fragile X awareness month, here are five things you may not know about FXS. (cdc.gov)
  • FRAGILE X SYNDROME AWARENESS MONTH Speaker: Michael Hart, CMCRC PhD Candidate, Western Sydney University. (cmcrc.com)
  • This month is Fragile X Syndrome Awareness month and CMCRC's Michael Hart is giving a presentation on FXS from his point of view as a parent. (cmcrc.com)
  • Your donation will help us support families affected by Fragile X, and to increase awareness of Fragile X associated conditions. (fragilex.org.au)
  • Fragile X syndrome is the most common form of inherited developmental disability . (medlineplus.gov)
  • Patients with mental retardation, developmental delay, autistic features, or a family history of Fragile X. (uab.edu)
  • Full text of the study, "Parent and caregiver perspectives toward cannabidiol as a treatment for Fragile X Syndrome," appears in Genes. (norml.org)
  • Furthermore, the human genome is estimated to contain about 80,000 genes, so many rare syndromes may have yet to be defined. (medscape.com)
  • To investigate the prevalence of fragile X syndrome (FXS) in intellectually disabled male and female Indonesians. (wjgnet.com)
  • Reisinger DL, Shaffer RC, Tartaglia N, Berry-Kravis E, Erickson CA. Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome. (medscape.com)
  • OV101 has previously been granted Orphan Drug status for Fragile X and Fast Track status for Angelman syndrome. (empr.com)
  • This study contributes to a greater understanding of the utility of molecular biomarkers to identify clinical phenotypes of fragile X syndrome (FXS). (bvsalud.org)
  • Fragile X Associated Primary Ovarian Insufficiency (FXPOI) is a disorder that may cause premature menopause and infertility in women who have this gene. (natural-fertility-prescription.com)
  • In this previous study, 87 patients had a chromosomal abnormality, five of whom expressed fragile sites on Xq27.3. (wjgnet.com)
  • The National Fragile X Research Registry's goal is to forward fragile X research by connecting scientists with a large number of families affected by fragile X syndrome and its associated conditions. (wisc.edu)
  • Fragile X syndrome (FXS) is the most common hereditary form of mental retardation. (scienceblog.com)
  • Newborn, carrier, and early childhood screening recommendations for fragile x. (medscape.com)
  • Even if you do not have Fragile X syndrome you can be a premutation carrier for FXS. (natural-fertility-prescription.com)
  • In families with a known fragile X history, testing can be done preconception (i.e., of an adult who wants to know if he or she is a carrier), prenatally, or in infancy. (hhs.gov)
  • Christine Gall, Gary Lynch and colleagues found that fragile X model mice trained in three short, repetitious episodes spaced one hour apart performed as well on memory tests as normal mice. (pediastaff.com)
  • Fragile X model mice trained using this method had memory scores equal to those of control animals," said Gall, professor of anatomy & neurobiology and neurobiology & behavior. (pediastaff.com)
  • Such outbreaks include Middle East respiratory syndrome (MERS), avian influenza A (H5N1), cholera and dengue. (who.int)
  • Systems and measures that are put in place need to be able to deal with extreme complexity, especially in relation to outbreaks in fragile States with weak institutions. (who.int)
  • You will contribute to a growing body of research looking at early language development in Fragile X syndrome that will support early intervention efforts. (fragilex.org)
  • Your support will help enable us to provide support to the Fragile X community around Australia through our HelpLine, specialist counselling, peer connections, educational webinars, referrals and advocacy. (fragilex.org.au)
  • But what is Fragile X syndrome, and what other research has been conducted around this neurodevelopmental disorder? (psychiatrictimes.com)
  • There are many more papers currently in development, and the future for Fragile X syndrome research is bright as more data is gathered. (fragilex.org)
  • Learn about observational and investigational - aka clinical trials - clinical research as it relates to Fragile X. Plus, watch Sharyn Lincoln and Katherine Pawlowski of Boston Children's Hospital on how clinical research trials work, what it takes to participate, and what happens after the study. (fragilex.org)
  • The plan was developed by the NIH Fragile X Research Coordinating Group, which includes representatives from multiple NIH Institutes, Centers, and Offices and relevant scientific, family, and advocacy communities. (nih.gov)
  • The professionals who are part of NFXF's Fragile X Clinical & Research Consortium (FXCRC) regularly review and update, as needed, the Fragile X treatment recommendations . (hhs.gov)
  • The Vanderbilt Kennedy Center will host a community forum June 20 to present information about current research on fragile X syndrome. (vumc.org)